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ABSTRACT
DYSREGULATION OF SYSTEM XC- AND ITS IMPACT
ON COCAINE SEEKING

Aric Madayag
Marquette University, 2012

Abnormal glutamate signaling in the brain, particularly in the nucleus accumbens
core, contributes to compulsive cocaine-seeking behavior. In the nucleus accumbens, two
distinct pools of glutamate exist. The synaptic pool stimulates excitatory postsynaptic
receptors, leading to cocaine seeking. Cystine-glutamate exchange by system xccontributes to the extrasynaptic pool and regulates neurotransmission by activating
extrasynaptic receptors including inhibitory Group II metabotropic glutamate receptors,
positioning this as an important mechanism for regulating nucleus accumbens activity.
We and others have found decreased levels of cystine-glutamate exchange in animals
withdrawn from chronic cocaine administration. In chapter 1, we describe studies directly
implicating diminished system xc- activity in abnormal glutamate signaling necessary for
promoting drug seeking. Given that altered system xc- activity is essential to drug
seeking, understanding the cellular basis of reduced cystine-glutamate exchange would
advance our knowledge of the neural basis of addiction. Unfortunately, little is known
about how the system is regulated. To address this, we sought to define conditions that
permit the study of system xc- (chapter 2). In chapter 3, we examined potential regulation
of xc- by dopamine, nonspecific dopamine agonists, D1-liked dopamine receptor
agonists, and D2-like dopamine receptor agonists. While we found D1-like receptor
regulation of cystine-glutamate exchange in mixed cortical culture, we did not observe
this effect in tissue punches; thus, it is unlikely that abnormal regulation of system xc- by
dopamine underlies reduced cystine-glutamate exchange in cocaine-withdrawn animals.
In chapter 4, we examined pituitary adenylyl cyclase activating polypeptide (PACAP)
because it has been recently shown to regulate extracellular glutamate homeostasis. We
found acute and tonic regulation of cystine-glutamate exchange by PACAP-induced
stimulation of Ca2+-dependent protein kinase (PKC) activity. More importantly, we also
determined that PACAP regulation of system xc- is diminished in animals withdrawn
from cocaine self-administration. These findings suggest dysregulated PACAP
neurotransmission in cocaine-withdrawn animals contributes to the neural basis of
addiction. By revealing novel mechanisms contributing to addiction, scientists can
identify novel targets for therapeutic treatment.
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-

Cystine-glutamate exchange
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cAMP-dependent protein kinase

PKC

-

Ca2+-dependent protein kinase

CPG

-

(S)-4-carboxyphenylglycine, inhibitor of system xc-
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-
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-
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-

dibutyryl cAMP, cAMP analog and activator of PKA
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-

5-Nitro-2-(3-phenylpropylamino)benzoic acid, selective chloride
channel blocker
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-

N-acetylcysteine, cysteine prodrug that stimulates cystine-glutamate
exchange
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-

Pituitary adenylyl cyclase activating polypeptide
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INTRODUCTION
Overview
The development of cocaine addiction is a result of neuroplasticity that leads to
compulsive use. The onset of cocaine use is due to a hedonic sensation when consumed
in enough quantities leads to tolerance, elevated levels of consumption, and eventually
addiction [for review, see (Hyman and Malenka, 2001)]. However, a compulsive pattern
of drug taking emerges after chronic use that is thought to be the direct result of druginduced plasticity (Hyman and Malenka, 2001, Pierce and Vanderschuren, 2010). Even
after extended withdrawal and abstinence from cocaine, people maintain a high
vulnerability to relapse (O'Brien et al., 1992, O'Brien et al., 1998). To date, there exists a
lack of effective clinical therapeutic treatments for cocaine addiction. To identify
effective therapeutics for preventing relapse, scientists must first reveal cocaineinduced
neuroplasticity that contributes to addiction and relapse susceptibility.
Cocaine-induced neuroplasticity affects most of the brain, and can lead to
compulsive drug seeking behavior (Hyman and Malenka, 2001, Pierce and
Vanderschuren, 2010). In order to focus studies on brain regions relevant to cocaine
seeking, the motive circuit is given serious attention. This is due to the fact that the
nucleus accumbens core of the motive circuit is the primary output region for this
circuitry. Investigators originally studied cocaine-induced long-term changes in
dopamine signaling in the nucleus accumbens core, this given that cocaine is primarily
viewed as a dopamine transporter blocker (Wise, 1984, Bradberry and Roth, 1989).
However, previous studies have found that during the reinstatement phase of the selfadministration model of addiction, described in detail below, not dopamine but rather
glutamate signaling in the nucleus accumbens core is necessary for reinstatement
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(Cornish and Kalivas, 2000). Though glutamate is necessary for reinstatement, what is
unknown are factors that determine different magnitudes of reinstatement, a potential
correlate to relapse vulnerability. In this thesis, we will investigate the contribution of
glutamate and dopamine signaling in the nucleus accumbens core to reinstatement
magnitude.
Glutamate neurotransmission is altered in animals withdrawn from repeated
cocaine administration (Wolf et al., 2004, Kalivas et al., 2005), which likely contributes
to addiction because abnormal activation of corticostriatal pathways correlates with
craving in humans (Breiter et al., 1997, Volkow et al., 1999, Volkow et al., 2005) and is
necessary for cocaine-seeking in rodents (Park et al., 2002, McFarland et al., 2003,
Schmidt et al., 2005). Therefore, targeting glutamate neurotransmission therapeutically is
likely to be an effective treatment for cocaine addiction.
Two distinct pools of extracellular glutamate in the nucleus accumbens core exist,
synaptic and extrasynaptic. Synaptic glutamate derives primarily from glutamatergic
neurons originating in the dorsomedial prefrontal cortex. Extrasynaptic glutamate is
contributed by astrocytic vesicular (Hepp et al., 1999, Araque et al., 2000, Jourdain et al.,
2007, Malarkey and Parpura, 2008) and non-vesicular sources (Baker et al., 2002, Moran
et al., 2005). Non-vesicular glutamate provided primarily by system xc- regulates
synaptic neurotransmission, and is decreased following withdrawal from cocaine selfadministration (Baker et al., 2002, Moran et al., 2005, Moussawi et al., 2011b).
Investigators have been able to directly target cystine-glutamate exchange to reduce
cocaine-seeking (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008). In addition,
restoration of cystine-glutamate exchange expression decreases cocaine-seeking
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(Knackstedt et al., 2010), but little is known about multiple aspects during withdrawal;
for example the contribution of diminished cystine-glutamate exchange to basal
extracellular glutamate and cocaine-evoked glutamate in animals withdrawn from
cocaine. In addition, the source of cocaine-induced decreases in cystine-glutamate has not
been studied thoroughly.
The purpose of this thesis is to determine the contribution of diminished cystineglutamate exchange in cocaine-seeking and what contributes to decreased cystineglutamate following repeated cocaine. In order to address the former, we manipulate
conditions that block cocaine-induced decreases in cystine-glutamate exchange. To
address the latter, we will first determine neuronal signaling that regulates cystineglutamate exchange. Below, I will describe in detail:


Circuitry involved in cocaine-seeking: the motive circuit



Behavioral models of addiction



Cocaine-induced neuroplasticity relevant to cocaine-seeking



The cellular and molecular basis of glutamate homeostasis



Cystine-glutamate exchange by system xc-
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The motive circuit
In order to effectively
identify pathological
neuroplasticity in addiction, a
detailed analysis of the circuitry
contributing to addiction will be
addressed. The motive circuit
(figure i.1) is a combination of
limbic circuit processing and
motor control, and plays a central
role in motivated behavior and
addiction (Wise, 1984, Kalivas
and McFarland, 2003, Kalivas et
al., 2005, Schmidt et al., 2005).

Figure i.1. Multiple projections to the nucleus accumbens
interact to determine behavioral output. Glutamatergic
projections from the PFC, vSub, BLA, and thalamus are
excitatory glutamate projections. Dopaminergic projections
from the VTA are modulatory. There also GABAergic
inhibitory inputs from the VP and VTA. PFC, prefrontal
cortex; vSub, ventral subiculum of the hippocampus; BLA,
basolateral amygdala; Mid, IL, midline and intralaminar
thalamaic nuclei; NAcc, nucleus accumbens; VP, ventral
pallidum; VTA, ventral tegmental area.

There exists two major divisions
of the NAcc. The core division is the central part located mostly surrounding the anterior
commissure. The shell division surrounds the core and occupies the ventral and medial
portions of the NAcc. Though the core and shell share similar neuronal composition of
medium spiny projection neurons (Meredith, 1999) in addition to cholinergic and
parvalbumin interneurons (Kawaguchi et al., 1995), they differ in efferent and afferent
pathways. Key among these distinct circuitry is the difference in excitatory input. For
example, the nucleus accumbens core receives glutamatergic input primarily from the
dorsomedial prefrontal cortex, whereas the nucleus accumbens shell receives input from
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the ventromedial prefrontal cortex, the ventral subiculum of the hippocampus, and the
amygdala (Kelley and Domesick, 1982, Kelley et al., 1982, Groenewegen et al., 1987,
Groenewegen et al., 1990, Kita and Kitai, 1990, McDonald, 1991). In addition to the
differential input to the core and shell of the nucleus accumbens, they also differ in their
functional downstream effects. While the nucleus accumbens core is the central
behavioral output region for the motive circuit (McFarland and Kalivas, 2001, Kalivas
and McFarland, 2003), the nucleus accumbens shell receives excitatory input to regulate
dopamine cell activity in the ventral tegmental area (Floresco et al., 2001, Floresco et al.,
2003, Goto and Grace, 2005). Investigators suggest that they also differ in their role in
behavior and reward processing (Carlezon et al., 1995, Volkow and Fowler, 2000, RoddHenricks et al., 2002, Kalivas and McFarland, 2003, Robbins et al., 2008).
As portrayed in figure i.1, input to the nucleus accumbens can be divided into
three major categories: excitatory (glutamatergic), inhibitory (GABAergic), and
modulatory (dopamine and other neuromodulators). Excitatory input comes primarily
from limbic areas such as the prefrontal cortex, entorhinal cortex, ventral subiculum of
the hippocampus, and the basolateral amygdala (Kelley and Domesick, 1982, Kelley et
al., 1982, Groenewegen et al., 1987, Kita and Kitai, 1990, McDonald, 1991, Berendse et
al., 1992, Brog et al., 1993, Totterdell and Meredith, 1997, Reynolds and Zahm, 2005), as
well as from the midline and intralaminar nuclei of the thalamus (Kelley and Stinus,
1984, Berendse and Groenewegen, 1990). Major inhibitory inputs derive from the ventral
tegmental area and the ventral pallidum (Brog et al., 1993, Groenewegen et al., 1993,
Churchill and Kalivas, 1994, Van Bockstaele and Pickel, 1995, Wu et al., 1996).
Dopamine input comes mainly from the midbrain ventral tegmental area (Voorn et al.,
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1986, Ikemoto, 2007). Understanding how these systems may be altered by chronic
cocaine will be important to understanding the neural basis of addiction.
Models of addiction: Conditioned Place Preference
Conditioned place preference (CPP) is widely used to test the rewarding
properties of drugs. It is based on classical conditioning whereby spatial cue-associated
chambers are paired to an injection of either drug (cocaine) or saline. During the
acquisition phase of CPP, an animal is first assessed for its “preference” for a particular
chamber in a drug naïve state. This allows the experimenter to follow a biased, unbiased,
or balanced procedure for the acquisition phase. In the biased method, the experimenter
gives an injection of a drug when animals in a group enter the same chamber throughout
the experiment, while the other is paired with a vehicle (i.e. saline) injection. The
experimenter generally pairs the drug injection with the chamber the animals did not
prefer in the drug naïve state. In the unbiased method, the drug paired compartment is
picked at random between animals. In the balanced method, each compartment is
assigned the same number of drug pairs across all animals. To determine the presence or
absence of CPP, an experimenter would compare the time spent in drug- and vehiclepaired compartments (Parker and McDonald, 2000). Investigators appreciate this method
based on the absence of contextual stimuli for which animals can acquire a secondary
preference (i.e. light or noise) (Tzschentke, 2007). Whereas the development of place
preference is a useful model for the rewarding properties of a drug, some experimenters
prefer to utilize the extinction/reinstatement model of relapse.
During extinction, the animal will either received a saline injection regardless of
the chamber entered, or will be allowed to fully explore both chambers without any
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injections. Animals will continue to be placed in the chamber until a preference is
extinguished. This stage in the paradigm allows an investigator to evaluate the
motivational properties of the drug administered during the acquisition phase, in the
absence of drug treatment.
Reinstatement of drug-paired behavior by a priming injection of the drug is a
reliable model for drug craving and relapse (De Vries et al., 1998, Shalev et al., 2002).
During the reinstatement phase of CPP, the animal receives an acute injection of drug or
a stressor. Of particular interest is the ability of a variety of psychostimulants to crossreact and reinstate CPP. For example, animals extinguished from cocaine CPP exhibit
reinstatement in the presence of a priming injection of methamphetamine, morphine,
nicotine, and ethanol (Itzhak and Martin, 2002, Romieu et al., 2004). An acute stressor is
also capable of reinstating CPP for cocaine (Lu et al., 2002, Sanchez et al., 2003).
There are advantages and disadvantages to the use of conditioned place
preference as a model of addiction. Pharmacological treatment intended to reverse drug
seeking during reinstatement may affect higher-level thought such as operant responding
found in the self-administration model, which is less likely to alter cocaine-seeking in the
CPP paradigm. In addition, the onset of “cocaine-seeking” by place preference is
relatively quicker than the self-administration paradigm given that the animal is not
required to learn operant responding. Disadvantages to this method include the lack of
flexibility in the paradigm during particular phases of the experiment. For example, while
the animal effectively prefers a chamber over the other, it is more difficult to determine
magnitude of drug-seeking and its relation to compulsion.
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Models of addiction: Self-administration
The self-administration model of addiction is a more widely used addiction
paradigm. In this model, an animal is surgically implanted with an intravenous catheter
and trained to respond (e.g. lever press or nose poke) to receive an infusion of drug (i.e.
cocaine) during the acquisition/maintenance phase (Clark et al., 1961, Weeks, 1962). As
in the acquisition phase of CPP, certain conditions of this phase allow the experimenter to
measure rewarding and reinforcing properties of the drug, supporting the abuse potential
of the drug (Johanson, 1990, Balster and Bigelow, 2003, Panlilio and Goldberg, 2007).
The experimenter may manipulate the responding required to receive an infusion of drug,
the two most common variations are fixed and progressive ratio [for review see (Arnold
and Roberts, 1997)]. Fixed ratio schedules, when a fixed number of responses are
required to receive drug infusion, are commonly used to measure the reinforcing
properties of a drug. On the other hand, progressive ratio schedules, when the number of
responses required to receive drug infusion “progressively” increases with each response,
are commonly used to measure the effectiveness of the reinforce; sometimes considered a
measure of the amount of work an animal is willing to exert, or willing to “pay”, to
receive the reinforcer. Some experimenters primarily utilize the acquisition/maintenance
phase, this due to the fact that in the clinical setting a patient is not likely to remain
abstinent unless under constant supervision.
Most investigators make use of the extinction/reinstatement model of selfadministration. During extinction, drug-seeking is extinguished by replacing the infusion
solution with saline or disconnection from the infusion pump. There are multiple variants
of extinction/reinstatement such as between-session, within-session, and between-within-
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session. In the between-session paradigm, the drug self-administration, extinction, and
reinstatement occur on consecutive days; for example an animal gains drug-seeking on
day one (or over multiple days), extinguishes drug-seeking the following day, and
undergoes reinstatement the day after that. In the within-session paradigm drug selfadministration, extinction, and reinstatement takes place sequentially within the same
day. The between-within-session paradigm, by definition, involves drug selfadministration across multiple days, and the extinction/reinstatement take place on a later
day, but within the same day of each other. A common variant of the between-within
paradigm involves a protracted withdrawal period following the self-administration phase
(Fuchs et al., 2006), extinction across multiple days until responding within each session
is minimal, and then reinstatement.
Following extinction, a stimulus such as drug, stress, or cue is provided to induce
reinstatement of drug-seeking. Reinstatement of drug-seeking is defined as operant
responding significantly higher than that observed on the last day of extinction. As in
conditioned place preference, there exists cross sensitization of psychostimulants to
induce reinstatement of drug seeking. Stress- (Erb et al., 1996, Shaham et al., 2000, Koob
and Le Moal, 2001) and cue-induced (See, 2002) reinstatement are of interest due to their
clinical relevance.
A distinct advantage of the self-administration paradigm is the ability to
manipulate conditions to allow for a measure of compulsive behavior. Previous studies
have shown that the level of cocaine intake during the maintenance phase of selfadministration alters both the onset of compulsive drug seeking as measured by escalated
intake during the maintenance phase, as well as elevated cocaine-induced reinstatement
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after withdrawal (Ahmed and Koob, 1998), providing a preclinical basis for comparing
recreational and addictive cocaine use.
Drug-induced plasticity in the nucleus accumbens and reinstatement
In the nucleus accumbens core, stimulation of glutamate (McFarland and Kalivas,
2001, Di Ciano et al., 2008) and dopamine (Spealman et al., 1999, Cornish and Kalivas,
2000, Park et al., 2002, Shalev et al., 2002) receptors is sufficient to produce drugseeking. However, blockade of glutamate (Cornish et al., 1999, Cornish and Kalivas,
2000, McFarland et al., 2003) but not dopamine (McFarland and Kalivas, 2001,
Anderson et al., 2003) receptors will abolish drug seeking. This suggests that long term
changes in glutamate signaling in the nucleus accumbens core may underlie cocaine
seeking behavior. This poses neuroplasticity involving glutamate in the nucleus
accumbens core as a key mechanism that may be capable of producing compulsive drug
seeking. In fact, studies have found long term changes in glutamate homeostasis and have
linked these adaptations to cocaine-seeking (Pierce et al., 1996, Baker et al., 2003), as
described below.
Glutamate homeostasis in the nucleus accumbens
There exists two distinct pools of extracellular glutamate, synaptic and
extrasynaptic. As it pertains to the nucleus accumbens core, synaptic glutamate derives
from glutamate terminals originating in the prefrontal cortex (Groenewegen et al., 1990,
Berendse et al., 1992, Brog et al., 1993). Propagation of an action potential leads to an
increase in calcium in the presynaptic terminal, resulting in docking and vesicular release
of glutamate into the synaptic cleft.
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Synaptic glutamate then targets both ionotropic and metabotropic glutamate
receptors. There are two primary ionotropic receptors, a low affinity a-amino-3hydroxy5-methyl-4-isoazole-proprionic acid (AMPA) and a high affinity N-methyl-Daspartic acid (NMDA), both named for selective exogenous ligands capable of activating
the receptors. The high affinity NMDA receptors are under constant blockage by a
voltage sensitive Mg2+-inhibitor. This magnesium blockade is removed when the cell is
sufficiently depolarized, usually by activation of AMPA receptors. These conditions
maintain a high signal/noise ration whereas sufficiently higher levels of glutamate are
required to stimulate AMPA receptors, leading to relief of the Mg2+ blockade on NMDA
receptors and further cellular depolarization.
Metabotropic glutamate receptors are G-protein coupled receptors categorized
into three families based on sequence homology [for review, see (Nakanishi, 1994)]:
Group I mGluRs, consisting of mGluR 1 and 5, activate Gq; Group II mGluRs, consistend
of mGluR 2 and 3, activate Gi; and Group III mGluRs, consisting of mGluRs 4, 6, 7, and
8 activate Gi. Synaptic metabotropic glutamate receptors are primarily Group I. Group I
receptors are primarily expressed on postsynaptic neurons and cholinergic neurons in the
striatum (Kerner et al., 1997, Pisani et al., 2001a, Pisani et al., 2001b, Marino et al.,
2002). Activation of postsynaptic Group I receptors facilitates synaptic signaling by
contributing to LTP and LTD (Gubellini et al., 2003). Group II and III receptors have
been localized to presynaptic excitatory terminals (Testa et al., 1998, Bradley et al., 1999,
Kosinski et al., 1999). Stimulation of these receptors leads to inhibition of glutamatergic
synaptic release in the striatum (Lovinger and McCool, 1995, Manzoni et al., 1997).

12

Synaptic glutamate is cleared from the synaptic space primarily by an excitatory
amino acid transporter (EAAT), of which there are five (EAAT 1-5). Glutamate transport
by an EAAT is coupled to the influx of three Na+ molecules, one H+ molecule, and efflux
of one K+ molecule (Zerangue and Kavanaugh, 1996, Levy et al., 1998, Owe et al.,
2006). Given that glutamate is a negatively charged amino acid, the electrical gradient
created by cotrans/antiport of these ions makes glutamate transport energetically
favorable. EAATs are located both at the synaptic cleft and in the extrasynaptic space.
This allows for functional separation of synaptic and extrasynaptic glutamate
compartments.
As portrayed in figure i.2,
extracellular glutamate derives from
multiple sources and regulates synaptic
activity. Glutamate release from
astrocytes can occur through multiple
mechanisms. Calcium-mediated glutamate
release from astrocytes is dependent on
storage of glutamate into vesicles and
release by the SNARE complex (Parpura
et al., 1995, Jeftinija et al., 1997, Hepp et
al., 1999, Araque et al., 2000, Pasti et al.,
2001, Montana et al., 2004, Crippa et al.,
2006). Ca2+-dependent glutamate
regulates synaptic activity by targeting

Figure i.2. Extrasynaptic glutamate derived from
astrocytes can regulate synaptic activity. (1)
Nonvesicular glutamate from cystine-glutamate
exchange stimulates presynaptic inhibitory Group
II receptors, decreases synaptic release of
neurotransmitter. (2) Ca2+-dependent vesicular
release of glutamate activates extrasynaptic
NMDA receptors, potentiating synaptic activity.
CC, cystine; G, glutamate; II, group II
metabotropic glutamate receptors; NMDA,
NMDA receptor; AMPA, AMPA receptor;
EAAT, excitatory amino acid transporter.
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extrasynaptic NMDA receptors (D'Ascenzo et al., 2007, Jourdain et al., 2007). Other
astrocytic sources of extrasynaptic glutamate include hemichannels (Ye et al., 2003),
volume-sensitive organic ion channels (Strange et al., 1996, Basarsky et al., 1999, Ye et
al., 2003), and cystine-glutamate exchange (Bannai, 1986, Murphy et al., 1990, Warr et
al., 1999, Baker et al., 2002, Moran et al., 2005).
Cystine-glutamate exchange by system xcCystine-glutamate exchange by
system xc- contributes to extrasynaptic
glutamate by stoichiometric exchange of
an extracellular cystine molecule for an
intracellular glutamate molecule
(Bannai, 1986, Murphy et al., 1990,
Warr et al., 1999, Baker et al., 2002,
Moran et al., 2005). System xc- is
comprised of two protein subunits. The
heavy chain subunit, 4f2hc is
nonspecific for amino acid transporter.
The functional subunit, xCT is specific
for system xc- and is necessary for
cystine-glutamate exchange (Shih and
Murphy, 2001). Cystine transport by
cystine-glutamate exchange is chloridedependent and sodium-independent

Figure i.3. Cystine-glutamate exchange regulates
synaptic activity. Glutamate derived from cystineglutamate exchange stimulates presynaptic Group II
receptors, which activates Gi signaling. Gi reduces
adenylyl cyclase activity and eventually PKA
activity, which under normal circumstances
increases activity of Ca2+channels that are necessary
for synaptic release of neurotransmitter. CC, cystine;
G, glutamate; II, group II metabotropic glutamate
receptors (mGluR2/3); AC, adenylyl cyclase, PKA,
protein kinase A.
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(Waniewski and Martin, 1984, Bannai, 1986), a key property that distinguishes it from
other more common amino acid transporters such as EAATs. Figure i.3 illustrates how
extrasynaptic glutamate from cystine-glutamate exchange stimulates presynaptic
inhibitory group II metabotropic glutamate receptors (mGluR2/3) (Baker et al., 2002,
Moran et al., 2005, Moussawi et al., 2011b), rendering it an essential mechanism for
normal synaptic function. Cocaine-induced decreases in cystine-glutamate exchange have
been found in animals withdrawn from chronic cocaine self-administration (Baker et al.,
2003, Moran et al., 2005, Kau et al., 2008, Moussawi et al., 2011b). As well, withdrawal
from chronic cocaine results in a decrease in basal extracellular glutamate (Pierce et al.,
1996, Baker et al., 2003), though others have found this not to be the case (Reid and
Berger, 1996). Decreases in basal extracellular glutamate likely contribute to the
augmented cocaine-evoked glutamate in the nucleus accumbens of cocaine-withdrawn
animals as extrasynaptic nonvesicular glutamate regulates synaptic transmission (Baker
et al., 2002, Moran et al., 2005, Moussawi et al., 2011b). To overcome this deficit, we
have targeted cystine-glutamate exchange both during reinstatement. Stimulating cystineglutamate exchange can reduce cocaine-primed reinstatement after protracted
withdrawal.
Given that altered system xc- activity is essential to elevated drug seeking, it is
important to know why it is diminished. Cystine-glutamate exchange has been shown
regulated in a tonic manner by interleukin-1(Jackman et al., 2010) and fibroblast
growth factor 2 (FGF-2) (Liu et al., 2011), and acutely by Group II receptors (Xi et al.,
2002a), protein kinase A (Baker et al., 2003) and protein kinase C (Tang and Kalivas,
2003). Further, evidence exists suggesting that dopamine regulates GLT-1 expression in
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the striatum (Brito et al., 2009). In addition, a novel neuropeptide, pituitary adenylyl
cyclase activating polypeptide (PACAP) has been shown to regulate glutamate
homeostasis by regulating activity of glial glutamate transporters in the striatum (Figiel
and Engele, 2000). In this dissertation, we will investigate regulation of cystine-glutamate
exchange by dopamine and PACAP.
Pituitary adenylyl cyclase activating polypeptide (PACAP)
PACAP was originally discovered and cloned from ovine hypothalamus in 1989,
and so named for its ability to stimulate adenylate cyclase and cAMP formation. Its first
discovery in the rodent brain was in the anterior pituitary from the hypothalamus (Miyata
et al., 1989). The first peptide discovered
was 38 amino acids long (PACAP38),
followed by discovery and cloning of
PACAP27, comprising of the first 27
amino acids of PACAP38 (Miyata et al.,
1990).
As illustrated in figure i.4,
PACAP is likely co-released with
glutamate from glutamatergic neurons.
This is based on studies showing that
PACAP colocalizes with vesicular
glutamate transporter 2 (VGLUT2)
(Engelund et al., 2010). This concept is
highly significant given that

Figure i.4. PACAP is likely co-released with
glutamate. An action potential leads to the Ca2+dependent release of PACAP from the nerve
terminal. PACAP stimulates postsynaptic and
astrocytic PAC1R in the nucleus accumbens core.
At this point, not much is known on how PACAP is
removed from the extracellular space or how it is
metabolized.
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glutamatergic signaling plays a major role in cocaine seeking. Unfortunately, not much
more is known regarding the regulation of PACAP release and how it is affected
following repeated consumption of cocaine.
PACAP binds to three G-protein coupled receptors, PAC1, VPAC1, and VPAC2.
PAC1 shows a higher affinity for PACAP over vasoactive intestinal peptide (VIP),
whereas VPAC1 and VPAC2 have similar affinities to the two neuromodulators. PAC1
receptor signaling is linked to both Gs or Gq mediated G-protein signaling. Three
different isoforms of PAC1 exist, which help determine which G-protein signaling
mechanism is activated. PAC1null and PAC1hop, of which there are hop1 or hop2, can
activate both Gq and Gs signaling thereby either increasing adenylyl cyclase activity and
increasing intracellular cAMP by Gs, as well as increasing intracellular calcium through
Gq mediated events. On the other hand, the hip isoform is only capable of increasing
adenylyl cyclase activity through Gs (Holighaus et al., 2011). There also exists a
PAC1hiphop isoform that is not well known. While sparse, literature suggests that
PAC1null and PAC1hop are the most abundant isoforms in the adult rat brain (Grimaldi
and Cavallaro, 1999, Lutz et al., 2006, Mustafa et al., 2007).
PACAP is distributed extensively throughout the central nervous system,
including the hypothalamus, cerebral cortex, amygdala, nucleus accumbens,
hippocampus, and cerebellum (Arimura et al., 1991, Hannibal, 2002); as well as the
autonomic nervous system (Sundler et al., 1996). The distribution of PACAP-projecting
neurons has been studied using in situ hybridization of PACAP mRNA as well as with
intracellular immunohistochemical labeling of PACAP. The highest density of PACAPexpressing fibers and cells bodes are found in the hypothalamus, particularly the
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paraventricular nucleus, the supraoptic nucleus (Koves et al., 1991, Hannibal et al.,
1995a, Hannibal et al., 1995b), the arcuate nucleus (Hannibal et al., 1995b, Murase et al.,
1995, Das et al., 2007), and the ventromedial hypothalamic nucleus (Hannibal et al.,
1995a, Skoglosa et al., 1999). Further, there is evidence of PACAP mRNA as well as
immunoreactive fibers in cortical regions, including the frontal cortex, neocortex,
cingulate, and entorhinal cortex (Mikkelsen et al., 1994, Hannibal et al., 1995a). In the
hippocampus, there is a moderate density of immunoreactive fibers and cell bodies
containing PACAP in the CA1, CA2, CA3, and dentate gyrus (Koves et al., 1991,
Skoglosa et al., 1999, Hannibal, 2002).
The use of PACAP and PAC1R knockout mice has revealed some phenotypes in
behavioral output. For example, investigators have shown that PACAP knockout mice
exhibit elevation in locomotion in the presence of anxiolytic behavior (Hashimoto et al.,
2001). More relevant to this purpose of this dissertation, one study has shown a lack of
difference in methamphetamine-induced behavioral sensitization when comparing wildtype and PACAP-deficient mice (Fujii et al., 2007); in short, though both groups
exhibited behavioral sensitization, neither group exhibited a significantly difference level
of sensitization.
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Summary
The current state of cocaine addiction research posits cystine-glutamate exchange
as a viable target for treatment (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008).
Table 1 lists the current state of cocaine-seeking as it pertains to diminished cystineglutamate exchange. Animals receiving sufficiently high levels of cocaine during selfadministration exhibit an escalation in consumption during self-administration (Ahmed
and Koob, 1998, Ahmed et al., 2003) and a decrease in cystine-glutamate exchange
(Baker et al., 2003, Moran et al., 2005, Kau et al., 2008).
Table 1. Known and unknown contributions of diminished cystine-glutamate
exchange to cocaine-seeking.
Known






Cystine-glutamate exchange regulates neurotransmission by stimulating
presynaptic inhibitor Group II receptors
Repeated cocaine by self-administration leads to a decrease in cystine-glutamate
exchange by system xcAnimals with cocaine-induced decreases in cystine-glutamate exchange also
exhibit diminished basal extracellular glutamate in the nucleus accumbens
Animals withdrawn from repeated cocaine, and thus diminished cystine-glutamate
exchange, exhibit cocaine-evoked glutamate after withdrawal
Acute restoration of cystine-glutamate exchange reduces cocaine-seeking

Unknown





Does diminished cystine-glutamate exchange a consequence of repeated cocaine,
does it contribute to basal extracellular glutamate, cocaine-evoked glutamate, and
reinstatement
What contributes to the magnitude of cocaine seeking (i.e. reinstatement)
What contributes to decreased cystine-glutamate exchange in cocaine-withdrawn
animals
What regulates cystine-glutamate exchange
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The aim of this dissertation will be to further advance the field by revealing
mechanisms that contribute to relapse vulnerability. As shown in Table 2, we will further
characterize neuroplasticity contributing to compulsive drug seeking and relapse
vulnerability. As well, we attempt to distinguish differential neurotransmitter signaling in
animals exhibiting elevated reinstatement. Though much is known regarding regulation
of glutamate homeostasis through glutamate transporters, little is known regarding the
regulation of cystine-glutamate exchange. We attempt to determine neuronal signaling
that may regulate system xc- and how it is effected following withdrawal from cocaine
self-administration. Altogether, findings in this dissertation should further the field of
cocaine addiction research, and reveal potential novel therapeutic targets.
Table 2. Aims and experimental approaches in this dissertation.
AIM
EXPERIMENT
Determine the contribution of cocaine
Block cocaine-induced neuroplasticity by
induced diminished cystine-glutamate
repeated stimulation of cystine-glutamate
exchange to basal extracellular glutamate, exchange during the maintenance phase of
cocaine-evoked glutamate, and
self-administration
reinstatement.
Determine what contributes to the
Alter cocaine intake during the
magnitude of reinstatement to help
maintenance phase of self-administration
understand relapse vulnerability
and determine differences in cocaineevoked neurochemistry, neuronal
signaling, and cystine-glutamate exchange
Determine the source of diminished
Measure regulation of cystine-glutamate
cystine-glutamate exchange in cocaineexchange by neuronal signaling, then
withdrawn animals
determine if this is altered in cocainewithdrawn animals
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CHAPTER 1

Contribution of diminished system xc- to cocaine-evoked neurochemistry
and cocaine-seeking
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Introduction
Repeated cocaine alters glutamate neurotransmission even following protracted
withdrawal (Wolf et al., 2004, Kalivas et al., 2005), and this likely contributes to
addiction since abnormal activation of corticostriatal pathways correlates with craving in
humans (Breiter et al., 1997, Volkow et al., 1999, Volkow et al., 2005) and is necessary
for cocaine seeking in rodents (Park et al., 2002, McFarland et al., 2003, Schmidt et al.,
2005). Revealing cellular mechanisms underlying altered corticostriatal activation should
advance our understanding of the neurobiological basis of addiction and identify novel
therapeutic targets (Volkow and Fowler, 2000, Dackis, 2004).
Models of pathological glutamate signaling proposed to underlie addiction need to
account for the existence of multiple pools of extracellular glutamate. Aside from
synaptic glutamate maintained by vesicular release, extrasynaptic glutamate is sustained
primarily by nonvesicular release (Herrera-Marschitz et al., 1996, Timmerman and
Westerink, 1997). In support, basal extrasynaptic glutamate sampled using microdialysis
are largely independent of vesicular glutamate (Westerink, 1995). Glutamate transporters
may partition the two pools by limiting glutamate overflow from the synapse into
extrasynaptic compartments (Danbolt, 2001), and restricting entry of nonvesicular
glutamate into synapses (Jabaudon et al., 1999). Although confined to the extrasynaptic
compartment, nonvesicular glutamate regulates neurotransmission by stimulating group
II metabotropic glutamate receptors (mGluRs) (Baker et al., 2002, Xi et al., 2002a) which
are extrasynaptic receptors capable of inhibiting vesicular release (Baskys and Malenka,
1991, Cochilla and Alford, 1998, Schoepp, 2001). Thus, extrasynaptic receptors permit
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crosstalk between the two pools and indicate that altered nonvesicular glutamate release
may contribute to pathological glutamate signaling linked to addiction.
Cystine-glutamate exchange via system xc- may be critical in the capacity of
extrasynaptic glutamate to regulate corticostriatal signaling in the normal and
pathological states. First, nonvesicular release from cystine-glutamate exchange
maintains basal extracellular glutamate in the nucleus accumbens (Baker et al., 2002, Xi
et al., 2002a), and thereby regulates the extent of endogenous group II mGluR stimulation
(Baker et al., 2002, Melendez et al., 2005, Moran et al., 2005). Repeated cocaine blunts
system xc- activity which leads to reduced basal and likely increased cocaine-evoked
glutamate in the nucleus accumbens that persists for at least three weeks after the last
cocaine treatment (Baker et al., 2003). These changes are relevant for drug seeking since
N-acetylcysteine, a cysteine prodrug used to drive system xc- (Williamson and Meister,
1981, Meister, 1985, Pileblad and Magnusson, 1992), blocks cocaine-evoked glutamate
in the nucleus accumbens and subsequent cocaine-induced reinstatement (Baker et al.,
2003). What is lacking is a clear demonstration that the changes in glutamate and
cocaine-seeking require reduced cystine-glutamate exchange.
In these studies, we test the hypothesis that diminished system xc- activity is part
of the neuroplasticity contributing to compulsive drug seeking. As shown in the
introduction, stimulating cystine-glutamate exchange during self-administration prevents
escalation of cocaine-seeking. We hypothesize that preventing escalation of cocaineseeking alters cocaine-induced neuroplasticity associated with reinstatement after
protracted withdrawal. Further, we also hypothesize that escalation of cocaine-seeking
results in long-term changes in cystine-glutamate exchange.
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Materials and Methods
Animals
These experiments utilized male Sprague Dawley rats (Harlan, Indianapolis, IN)
weighing 275–325 grams upon arrival. Rats were individually housed in a temperaturecontrolled colony room with a 12-h reversed light/dark cycle. Housing conditions and
experimental protocols were approved by the Marquette University Institutional Animal
Care and Use Committee and carried out according to the NIH Guide for the Care and
Use of Laboratory Animals (revised 1996).
Surgeries
Rats were implanted with indwelling catheters under ketamine HCl (100 mg/kg,
IP, Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, IP, Lloyd
Laboratories, Shenandoah, IA, USA) anesthesia. A silicon tubing catheter (Dow Corning
Co., Midland, MI; 0.64 mm ID; 1.19 mm OD) was implanted such that it entered the
jugular vein through the right posterior facial vein and terminated at the right atrium. The
catheter was sutured to the vein at the entry point. The distal aspect of the catheter, which
consisted of a 22-gauge guide cannula (Plastics One Inc., Roanoke, VA) attached with
dental acrylic to a piece of polypropylene monofilament surgical mesh (Atrium Medical,
Co., Hudson, NH), exited 2 cm posterior to the scapulae. Throughout the experiment,
catheters were filled daily with a heparin solution (83 i.u./ml; Elkins-Sinn, Inc., Cherry
Hill, NJ) and capped when disconnected from the leash/delivery line assembly. Rats were
also implanted with indwelling bilateral guide cannulae (20 gauge, 14 mm; Plastics One,
Roanoke VA) using the following coordinates derived from Paxinos and Watson (1986):
+ 0.9 mm anterior, ± 2.5 mm mediolateral to Bregma, and −4.4 mm from the surface of

24

the skull at a 6° angle from vertical. The placement of the active region of the
microdialysis probe, which began 1 mm beyond the ventral tip of the guide cannulae, was
primarily in the NAcc although regions immediately dorsal and ventral to this were also
likely sampled. Following surgery, rats were given at least five days to recover prior to
testing. During this time, rats were provided acetaminophen (480 mg/L) in their drinking
water and injected daily with a sterile cefazolin antibiotic solution (15 mg, IV; WestWard Pharmaceutical Co., Eatontown, NJ).
Cocaine Self-Administration Training
Self-administration occurred in operant conditioning chambers (ENV-008CT,
MED-Associates Inc., St Albans, VT, USA) housed in sound attenuating cubicles (ENV016M, MED-Associates Inc.) and equipped with two retractable levers, two stimulus
lights, and a water bottle. At least five days after surgery, rats were food restricted with
water available ad libitum; food restriction continued for the duration of the experiment
(e.g., through reinstatement testing) and involved daily administration of 15 grams of rat
chow in the late afternoon or immediately following an operant session. Rats were then
placed into the operant conditioning chambers overnight and responses on the lever
designated as active resulted in the delivery of food pellets under a fixed ratio 1 schedule
of reinforcement. Daily food training continued until subjects received at least 150 food
rewards in a session, which typically occurred following the first session. During the
acquisition phase of the experiment, all rats underwent drug self-administration training
during daily 2-hr sessions in which operant responses on the active lever were reinforced
with an infusion of cocaine (0.5 mg/kg/200μl infusion, IV, National Institute on Drug
Abuse, Bethesda, MD, USA) under a fixed ratio 1 schedule of reinforcement. Each
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reinforced lever response resulted in the illumination of the stimulus light located above
the active lever and was followed by a 25-s time-out period. Responding on a second,
inactive lever located on the back wall was recorded but had no programmed
consequences. Acquisition of cocaine self-administration was operationally defined as <
10% variation in daily responding over at least three consecutive sessions. During the
maintenance phase of the experiment, rats were assigned to self-administer cocaine under
low- (0.5 mg/kg/200μl infusion, IV, 2 hrs/day) or high-intake conditions (1.0
mg/kg/200μl, IV, 6 hrs/day) for 11 days.
Extinction/Reinstatement testing
After completing eleven maintenance self-administration sessions, rats remained
in their home cages for seven days prior to extinction training. The seven day delay was
used to ensure an adequate drug-free period prior to reinstatement, even in rats that
quickly extinguished responding. Extinction training involved placing rats into the
operant conditioning chambers for 2-hr/day as described above except each active lever
press now resulted in an infusion of saline. This continued until the mean number of lever
presses was ≤ 10 responses across at least three sessions, at which point rats were tested
for drug-primed reinstatement. The reinstatement test day was identical to each extinction
session except rats were injected with cocaine (10 mg/kg, IP). Because the mean number
of extinction sessions needed to meet criteria (± SEM) was 12.2 ± 1.2, reinstatement
testing occurred approximately 19 days after the last self-administration session.
In vivo Microdialysis Testing
On the night before testing, microdialysis probes, constructed as previously
described (Baker et al., 2003), were inserted into indwelling guide cannula. Rats were
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then housed overnight in the self-administration chambers. The next day, dialysis buffer
(5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM MgCl2, and 0.15% phosphate
buffer saline, pH 7.4) was pumped through the probes at a rate of 1 μl/min for at least 3
hr to permit an adequate period of time for neurotransmitter levels to stabilize.
Afterwards, twenty min samples were collected as described below for each experiment.
Quantification of Glutamate
The concentration of glutamate in dialysis samples was quantified by comparing
peak heights from samples and external standards using HPLC coupled to fluorescence
detection. Precolumn derivatization of glutamate with opthaldehyde was performed using
a Shimadzu LC10AD VP autosampler. The mobile phase consisted of 13% acetonitrile,
100 mM Na2HPO4, and 0.1 mM EDTA, pH 5.90. Glutamate was separated using a
reversed-phase column (4 μm; 140 × 6.0 mm; Phenomenex, Torrance, CA), and detected
using a Shimadzu 10RF-AXL fluorescence detector with excitation and emission
wavelengths of 320 and 400 nm, respectively.
Quantification of Dopamine
Dopamine concentrations were quantified by comparing peak heights from
samples and external standards using HPLC coupled to electrochemical detection. The
mobile phase consisted of 15% acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM
citric acid, 3 mM SDS, and 50 μM EDTA, pH 5.6. Dopamine was separated using a
reversed-phase column (3 μm; 80 × 3.2 mm; ESA Inc., Bedford, MA) and detected using
an ESA Coulochem II detector coupled to two electrodes set at −0.075 V and +0.25 V,
respectively.
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[35S] Cystine uptake ex vivo
Rats were decapitated and the brains were rapidly extracted and cut into 2 mm
coronal slices using a brain matrix. Tissue punches (1.25 mm diameter; Stoelting, Wood
Dale, IL) were collected from the nucleus accumbens core and incubated at 37°C for ∼30
min on a nylon bolting cloth platform, submerged beneath 2 mm of standard buffer
(Lobner and Lipton, 1993); the standard buffer contained 124 mM NaCl, 3.0 mM KCl,
1.4 mM KH2PO4, 1.3 mM MgSO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 4 mM glucose,
equilibrated with 95% O2, 5% CO2, pH 7.4. After a 30 min wash, the tissue was
incubated for 30 min in standard buffer containing [35S]cystine (4 μCi/ml; GE Healthcare,
Piscataway, NJ). D-Aspartate (1 mM) was also added to the incubation buffer to prevent
uptake via XAG. After 30 min incubation, the tissue punches were washed four times in
ice-cold standard buffer and dissolved in 250 μl of 1% SDS. One aliquot (100 μl) was
used to measure [35S]cystine uptake by scintillation counting; a second aliquot (100 μl)
was used to assess protein content by the BCA method. Additional punches from each
subject were processed as described above with the exception that unlabeled CPG [(S)-4carboxyphenylglycine] (1 mM) was added 10 min before and for the duration of the 30
min incubation with [35S]cystine (4 μCi/ml). These values reflect labeling independent of
system xc− and were subtracted from the total labeling obtained from each subject to get
a measure that solely reflected uptake through cystine–glutamate exchange.
Experiment 1: Impact of repeated N-acetylcysteine on cystine-glutamate exchange in
cocaine-withdrawn animals
N-acetylcysteine (Sigma, St. Louis, MO) is a cysteine prodrug that stimulates
cystine-glutamate exchange (Moldeus et al., 1981, Meister, 1985). Animals underwent
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self-administration training and during the maintenance phase were pretreated with saline
or N-acetylcysteine (60mg/kg, IP) one hour prior to daily saline or cocaine selfadministration (1.0mg/kg/200L infusion, IV 6 hrs/day) for 11 days. This produced four
treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc. After protracted withdrawal
of at least 7 days, animals were rapidly decapitated and measure for ex vivo cystine
uptake in the nucleus accumbens core as described above.
Experiment 2: Impact of repeated N-acetylcysteine on basal extracellular glutamate
Animals underwent self-administration training and during the maintenance
phase were pretreated with saline or N-acetylcysteine (60mg/kg, IP) one hour prior to
daily saline or cocaine self-administration (0.5mg/kg/200L infusion, IV 2hrs/day) for 11
days. This produced four treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc.
Animals then underwent 7 days of withdrawal and extinction training. After the last day
of extinction training, animals were placed into the self-administration chambers and
underwent microdialysis as described above. To determine the level of basal extracellular
glutamate, the first 3 samples were quantified for glutamate and area under the curve
(AUC) was calculated.
Experiment 3: Impact of repeated N-acetylcysteine on cocaine-evoked glutamate
Animals underwent self-administration training and during the maintenance
phase were pretreated with saline or N-acetylcysteine (60mg/kg, IP) one hour prior to
daily saline or cocaine self-administration (0.5mg/kg/200L infusion, IV 2hrs/day) for 11
days. This produced four treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc.
Animals then underwent 7 days of withdrawal and extinction training. After the last day
of extinction training, animals were placed into the self-administration chambers and
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underwent microdialysis as described above. To determine the magnitude of cocaineevoked glutamate, after the baseline was established all animals received an injection of
cocaine (10mg/kg, IP) and the self-administration chamber was activated. Glutamate
levels were normalized to the mean of the 3 baseline samples.
Experiment 4: Impact of repeated N-acetylcysteine on cocaine-primed reinstatement
Animals underwent self-administration training and during the maintenance
phase were pretreated with saline or N-acetylcysteine (60mg/kg, IP) one hour prior to
daily saline or cocaine self-administration (0.5mg/kg/200L infusion, IV 2hrs/day) for 11
days. This produced four treatment groups, Sal-Sal, NAC-Sal, Sal-Coc, and NAC-Coc.
Animals then underwent 7 days of withdrawal and extinction training. After the last day
of extinction training, animals were placed into the self-administration chambers and
underwent reinstatement as described above.
Histology
Rats included in the microdialysis studies were given an overdose of pentobarbital
(60 mg/kg, IP), and the brains were fixed by intracardiac infusion of 0.9% saline
followed by 2.5% formalin solution. Brains were removed and stored in 2.5 % formalin
for at least seven days prior to sectioning. The tissue was then blocked and coronal
sections (100 μM) were cut and stained with cresyl violet to verify probe placements.
Statistical analyses
SPSS software (version 16) was used to perform the statistical analyses. Data were
analyzed using analysis of variance (ANOVA) with self-administration access conditions
and N-acetylcysteine dose as potential between-subject factors and time (20-min interval)
as a repeated factor. Post hoc comparisons were conducted using t-tests when only two
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data points were compared. Other post hoc comparisons are as noted. Note, the p value
required for significance in the post hoc tests are adjusted downward by the total number
of comparisons conducted to control for alpha inflation.

31

Results
Experiment 1: Impact of repeated N-acetylcysteine on cystine-glutamate exchange in
cocaine-withdrawn animals
Figure 1.1 illustrates the impact of daily
N-acetylcysteine pretreatment on
cocaine-induced plasticity involving
system xc-. A comparison of [35S]cystine
transport produced an interaction
between N-acetylcysteine and cocaine
treatment conditions (F1,31= 7.53;
p=0.01). Post hoc analyses revealed that
rats pretreated with saline before cocaine
self-administration exhibited reduced
[35S]cystine transport relative to saline

Figure 1.1. Daily N-acetylcysteine prevents longterm deficits in cystine-glutamate exchange in the
nucleus accumbens produced by repeated cocaine.
Cystine transport was measured in tissue punches
from the nucleus accumbens after withdrawal from
self-administration. *Significant difference from
Sal-Sal controls.

controls (Dunnett's t, p<0.05). Furthermore, rats pretreated with N-acetylcysteine before
cocaine self-administration failed to exhibit diminished cystine–glutamate exchange,
although cystine uptake was measured 23–34 d after the last treatment of either cocaine
or N-acetylcysteine (Dunnett's t, p<0.05).
Experiment 2: Impact of repeated N-acetylcysteine on basal extracellular glutamate
Cystine-glutamate exchange is diminished in the nucleus accumbens of animals
withdrawn from cocaine self-administration (Baker et al., 2003). As well, cystineglutamate exchange regulates synaptic neurotransmission (Baker et al., 2002, Moran et
al., 2005, Moussawi et al., 2011b). We wanted to determine if chronic stimulation of
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cystine-glutamate exchange and
therefore constant regulation of synaptic
signaling, during cocaine selfadministration will reverse deficits
found in basal and cocaine-evoked
glutamate. Figure 1.2 illustrates that
chronic treatment with the cysteine
prodrug N-acetylcysteine restores basal
glutamate during withdrawal. A

Figure 1.2. Daily N-acetylcysteine prevents longterm changes in extracellular basal glutamate levels
in the nucleus accumbens produced by repeated
cocaine. Basal glutamate levels are depicted as area
under the curve calculated using samples collected
before the cocaine injection. *Significant difference
from Sal-Sal controls.

comparison of basal glutamate (before
cocaine primer) as measured by area under the curve yielded a significant interaction
between N-acetylcysteine and cocaine treatments (ANOVA: F1,37=4.05, p<0.05). Post
hoc analyses revealed that a reduction in basal glutamate relative to saline controls was
found in rats pretreated with daily saline before cocaine self-administration sessions
(Dunnet’s t, p<0.05), a significant difference was also found when comparing with rats
that had been treated with N-acetylcysteine during self-administration training (Dunnet’s
t, p<0.05).
Experiment 3: Impact of repeated N-acetylcysteine on cocaine-evoked glutamate
Increased glutamate signaling in the nucleus accumbens is necessary for cocaineseeking during reinstatement. As well, others have shown that only animals withdrawn
from repeated cocaine exhibit cocaine-evoked glutamate. We wanted to determine if
cocaine-evoked (10 mg/kg, IP) glutamate is absent in animals that underwent selfadministration but exhibit normal levels of cystine-glutamate exchange and basal
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glutamate. An ANOVA comparing
cocaine-evoked glutamate during
reinstatement (Figure 1.3) with Nacetylcysteine and cocaine treatment as
between-subjects measures and time (20
min samples) as a repeated measure
yielded a significant three-way
interaction (F8,296=2.05, p<0.05). Post
hoc analyses revealed that animals
pretreated with saline prior to daily
cocaine self-administration session
exhibited significantly higher levels of
Figure 1.3. Daily N-acetylcysteine prevents changes
in cocaine-evoked extracellular glutamate levels in
the nucleus accumbens produced by repeated
cocaine. Cocaine-evoked glutamate is presented as
percent change from baseline (a) or area under the
curve calculated using samples collected after the
cocaine injection (b). *Significant difference from
Sal-Sal controls; +Significant difference from the
last baseline sample; #Significant difference from
NAC-Coc rats.

cocaine-evoked glutamate during
reinstatement (Figure 1.3a; Dunnet’s t,
p<0.05), though there was no significant
difference found in animals treated with

N-acetylcysteine prior to daily cocaine self-administration. When measuring area under
the curve (AUC), a significant interaction between N-acetylcysteine and cocaine
treatment was observed (Figure 1.3b; F1,37=4.05, p<0.05). Post hoc analyses yielded a
significant increase in glutamate in rats pretreated with saline before cocaine selfadministration when compared to animals pretreated with N-acetylcysteine (Dunnet’s t,
p<0.05).
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Experiment 4: Impact of repeated N-acetylcysteine on cocaine-primed reinstatement
The above findings show that diminished cystine-glutamate exchange contributes
to altered basal and cocaine-evoked glutamate. We wanted to determine if it also
contributes to cocaine-primed reinstatement. Figure 1.4 illustrates the impact of repeated
N-acetylcysteine on the last three extinction sessions and cocaine-primed (10mg/kg, IP)
reinstatement in animals withdrawn
from short-access cocaine-self
administration conditions
(0.5mg/kg/200L infusion, IV, 2
hrs/day). N-acetylcysteine administered
during self-administration did not alter
Figure 1.4. Daily N-acetylcysteine prevents
cocaine-induced reinstatement. Data depict mean ±
SEM behavior during the last three extinction
sessions and following a cocaine-primer (10mg/kg,
IP) for groups treated as designated during selfadministration. *Significant difference from the last
extinction session; Dunnet’s t, p<0.05. #Significant
difference from all other groups; Dunnet’s t, p<0.05.

the number of extinction session
required to meet criteria when compared
to cocaine animals pretreated with saline
(Mean ± SEM: NAC, 11 ± 2; Sal, 13.6 ±

1.7; Student’s t, p>0.05). In contrast a comparison of lever pressing during the
reinstatement test day and the last three extinction sessions produced a three-way
interaction between test day, N-acetylcysteine treatment, and cocaine treatment
(ANOVA: F3,111=3.06, p<0.05). Post hoc analyses revealed that a cocaine primer
reinstated extinguished drug seeking, evident as a significant increase in lever pressing on
the reinstatement test relative to the last extinction session, but only in rats that had been
treated with saline and cocaine during self-administration (Dunnet’s t, p<0.05); this group
of rats also exhibited significantly higher levels of responding on the reinstatement test
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day compared to all other groups (Dunnet’s t, p<0.05). In contrast, cocaine rats pretreated
with N-acetylcysteine failed to reinstate cocaine-seeking despite testing 2-3 weeks after
the last N-acetylcysteine treatment.
-----------------------------------------------------------------------------------------------------------The above findings suggest that diminished cystine-glutamate exchange by cocaine-selfadministration contributes to the following:




Diminished basal extracellular glutamate in the nucleus accumbens
Cocaine-evoked glutamate in the nucleus accumbens
Cocaine-primed reinstatement
These findings reveal diminished cystine-glutamate exchange by system xc- as a

necessary event for decreased basal glutamate, increased cocaine-evoked glutamate, and
cocaine-primed reinstatement. Thus reduced system xc- activity may be critical to the
transition of drug-seeking from casual to compulsive. To further test this, we examined
the status of cystine-glutamate exchange under conditions that have been shown to
produce elevated levels of cocaine intake and heightened cocaine-primed reinstatement.
Previous studies have suggested that animals consuming elevated levels of cocaine
during self-administration exhibit elevated reinstatement (Ahmed and Koob, 1998,
Ahmed et al., 2003). In the next section, we test the hypothesis that high-intake rats
(1.0mg/kg/200L infusion, IV, 6 hrs/day) exhibiting heightened reinstatement of
cocaine-seeking display a more robust cocaine-induced increase in extracellular
glutamate in the nucleus accumbens compared to low-intake rats (0.5mg/kg/200L
infusion, IV, 2 hrs/day) given that glutamate is necessary for cocaine-seeking (Park et al.,
2002, McFarland et al., 2003, Schmidt et al., 2005). Given that diminished cystine-
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glutamate exchange is essential to cocaine-evoked neurotransmission and reinstatement,
as shown in the previous section, we hypothesize that animals receiving high-intake
cocaine during self-administration exhibit diminished cystine-glutamate exchange
compared to low-intake animals.
-----------------------------------------------------------------------------------------------------------Cocaine-evoked extracellular glutamate is not affected by cocaine self-administration
intake conditions
Glutamate neurotransmission in the nucleus accumbens following cocaine selfadministration is altered and is necessary for cocaine-seeking as shown above and in
previous findings (Pierce et al., 1996, Torregrossa et al., 2008, Suto et al., 2009). We
hypothesized that animals consuming higher levels of cocaine show augmented glutamate
neurotransmission during reinstatement. In animals that received either high- or lowintake conditions, we measured cocaine-evoked glutamate by microdialysis during the
reinstatement phase. Figure 1.5a illustrates that there was no significant difference in
cocaine-evoked glutamate release between low- and high-intake animals. An ANOVA
with time (20 minute samples) as a repeated measure and intake conditions as a between
subjects factor yieled a significant main effect of time (F10,350=4.32, p<0.001), no
significant main effect of intake (F1,35=0.101, p=0.752), nor an interaction between the
variables (F10,350=0.773, p=0.655). Post hoc analyses revealed significant increases in
cocaine-evoked glutamate for both low- and high-intake animals in 4 of the samples
collected after the cocaine injection regardless of intake condition (Fisher LSD, p<0.008).
To verify the lack of a difference in cocaine-evoked glutamate between low- and highintake animals, we measured area under the curve (AUC) for samples collected after the
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Figure 1.5. Cocaine-evoked extracellular glutamate
in the nucleus accumbens is not different between
low- and high-intake animals. A cocaine primer (10
mg/kg, i.p.) was given to low- and high-intake
animals, and extracellular glutamate was measured
(a, b). There there was no significant effect after
cocaine injection (a, F10,350=0.773, p=0.655) or
when comparing cocaine-evoked glutamate as
measured by area under the curve (b, t35=0.5,
p=0.691) despite the fact that the high-intake
animals exhibited a significant increase in cocaineinduced reinstatement (t33=4.476, p<0.001).
*Significant difference from the last baseline
sample. #Significant difference from low-intake
animals.
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exhibited only in animals withdrawn from repeated cocaine. However, glutamate is not
essential for heightened reinstatement as shown above. Dopamine is not necessary for
cocaine-primed reinstatement as by blocking dopamine signaling in the nucleus
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accumbens does not abolish reinstatement. Conversely, elevating dopamine signaling in
the nucleus accumbens either by microinjection of dopamine or activating dopamine
receptors is sufficient to induce reinstatement. Therefore, we hypothesized that while
dopamine is not necessary for reinstatement, it determines the magnitude of
reinstatement. Figure 1.6a illustrates extracellular dopamine levels in the NAcc before
and after a cocaine injection (10 mg/kg, i.p.) in high- and low-intake rats when tested
after withdrawal and extinction from cocaine self-administration. An ANOVA with
intake conditions as a between-subjects factor and time (20 min samples) as a repeated
measure yielded a significant interaction (F10,230=4.14, p<0.001). An augmented cocaineinduced increase in extracellular dopamine was evident in high-intake rats when areas
under the curve were calculated using all of the postinjection samples and compared
across low- and high-intake conditions (Fig 1.6b; t23=2.143, p=0.043). As expected, the
high-intake group in this microdialysis study exhibited augmented reinstatement relative
to low-intake rats (Fig. 1.6c; t32=5.689, p<0.001).
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Figure 1.6. High-intake cocaine self-administration
augments both cocaine-evoked extracellular
dopamine levels in the nucleus accumbens core
presented as femtomoles/L as well as
reinstatement. A cocaine primer (10 mg/kg, i.p.) was
given to low- and high-intake animals, and
extracellular dopamine was measured (a, b). Post
hoc analyses reveal a significant effect of intake
condition as measured by areas under the curve (b,
t23=2.143, p=0.043), as well as reinstatement (c,
t32=5.689, p<0.001). *Significant difference from
last baseline sample (Fisher LSD, p<0.05).
#Significant difference from low-intake animals.
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altered based on cocaine intake conditions. We want to determine if this effect is
behaviorally relevant. We hypothesized that elevated dopamine stimulates D1-like
dopamine receptors leading to augmented reinstatement. Therefore, we reverse dialyzed
the D1-like dopamine receptor antagonist, SCH-23390 (0 or 10M) and determined if
receptor blockade alters cocaine-primed reinstatement. This concentration of SCH-23390
was determine based on previous published usage (Anderson et al., 2003, Schmidt et al.,
2006, Schmidt and Pierce, 2006). Figure 1.7 depicts responding during extinction and
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reinstatement testing in rats when
conducted in the absence (Fig. 1.7a) or
presence of SCH-23390 (Fig. 1.7b)
infused into the NAcc via reverse
dialysis. An ANOVA with intake
conditions and SCH-23390
concentration (0 or 10μM) as betweensubjects factors and experimental test
phase (extinction, reinstatement) as a
repeated measure yielded a three-way
interaction (F1,31=16.99, p<0.001).
Two separate ANOVAs (in the
Figure 1.7. Augmented cocaine-primed reinstatement
in high-intake animals is due to stimulation of D1-like
dopamine receptoirs. Data depict responding during
extinction and cocaine-primed reinstatement testing in
the absence (a) or presence (b) of SCH-23390. SCH23390 (0 and 10 μM) was infused into the nucleus
accumbens core via reverse dialysis beginning 1 hour
before the cocaine primer (10mg/kg, IP) and for the
duration of the experiment. +Significant difference
from low-intake rats (t test, p < 0.001). *Significant
difference from extinction responding (a, t test, p <
0.001; b, ANOVA main effect, p < 0.05).

presence or absence of SCH-23390
infusion) were then conducted to
deconstruct the three-way interaction
with intake conditions as a betweensubjects variable and experimental
phase as a repeated measure. In the

absence of SCH-23390, a two-way interaction (F1,17=25.93, p<0.001) was obtained.
Subsequent post hoc comparisons indicated that both intake groups exhibited significant
reinstatement, and that the high-intake group exhibited higher levels of responding during
the test for reinstatement relative to low-intake rats (t test, p < 0.0125). In the presence of
SCH-23390, there was a main effect of experimental phase (F1,14=14.28, p<0.05), without
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a significant main effect of intake conditions (F1,14=0.002, p=0.965) or an interaction
between the variables (F1,14=0.028, p=0.870).
N-Acetylcysteine blocks augmented cocaine-evoked dopamine in high-intake cocaine selfadministration animals
Restoring or preventing reduced
cystine-glutamate exchange by system
xc- in cocaine-withdrawn animals
lowers reinstatement and eliminates
cocaine-evoked glutamate after
withdrawal. We wanted to determine if
augmented cocaine-evoked dopamine
found in high-intake animals during
reinstatement is affected by cystineglutamate exchange. We pretreated
high-intake animals with the cysteine
prodrug N-acetylcysteine just prior to a
cocaine primer and measured
extracellular dopamine. Figure 1.8a
illustrates the effectiveness of Nacetylcysteine (NAC) in reducing
cocaine-evoked extracellular dopamine
in high-intake cocaine selfadministration animals. An ANOVA

Figure 1.8. Stimulating cystine-glutamate exchange
diminishes elevated cocaine-evoked dopamine in
animals withdrawn from high-intake cocaine selfadministration. Extracellular dopamine in the
nucleus
accumbens
core
presented
as
femtomoles/mL (a) or area under the curve (b)
calculated from the samples collected following the
cocaine injection. Microdialysis was used to sample
extracellular dopamine in the nucleus accumbens
core before and after injection of N-acetylcysteine
(NAC, 0 or 60 mg/kg, i.p., N = 10-11/group) and
cocaine (10 mg/kg, i.p.). *Significant difference
from baseline. #Significant difference from 0 Nacetylcysteine group.
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with NAC (0 or 60 mg/kg i.p.) as a between-subjects variable and time (20 min samples)
as a repeated measure yielded a significant interaction (F13,247=14.9850, p<0.001).
Pretreatment with NAC diminished cocaine-induced increases in extracellular dopamine
when areas under the curve were calculated using all of the post-injection samples and
compared across pretreatment (Fig 1.8b;
t19=2.148, p=0.045).
When combining all animals from figure 1.5 and figure 1.6, we found a
significant correlation between reinstatement and cocaine-evoked dopamine as measured
by areas under the curve (Pearson Correlation; r2 = 0.313, p<0.05), suggesting a link
between the cocaine-evoked neurochemical and behavioral responses.
Self-administration intake conditions result in differential altered system xc- activity
Figure 1.9 illustrates that animals
withdrawn from high-intake cocaine selfadministration exhibit diminished cystineglutamate

exchange

in

the

nucleus

accumbens core when compared to lowintake animals as measured by [14C]cystine
transport ex vivo (t7=2.36, p<0.05).

Figure 1.9. High-intake conditions decrease
cystine-glutamate exchange. Ex vivo tissue
punches from the nucleus accumbens core are
measured for [14C]cystine transport and
normalized to drug naïve animals following
withdrawal from cocaine self-administration.
*Significant difference from low-intake animals
(t7=2.36, p<0.05).
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Discussion
The aim of this chapter was to show that diminished cystine-glutamate exchange
contributes to cocaine-seeking behavior. Stimulating cystine-glutamate exchange with the
cysteine prodrug N-acetylcysteine (NAC) just prior to daily cocaine self-administration
blocked cocaine-induced deficits in cysteine-glutamate exchange. Animals with
functional cystine-glutamate exchange exhibited normal basal extracellular glutamate and
a lack of cocaine-evoked extracellular glutamate in the nucleus accumbens during
reinstatement. These findings suggest that diminished cystine-glutamate exchange by
system xc- and basal extracellular glutamate are essential to cocaine-evoked glutamate
and reinstatement, likely due to the fact that extracellular glutamate from cystineglutamate exchange regulates neurotransmission (Baker et al., 2002, Moran et al., 2005,
Moussawi et al., 2011b).
Though we were able to block cocaine-induced deficits in cystine-glutamate
exchange by repeated treatment with N-acetylcysteine during the maintenance phase of
self-administration, it is unclear how this takes place. We show that drug naïve animals
do not exhibit cocaine-evoked glutamate in the nucleus accumbens (figure 1.2), however
others have shown that an acute intraperitoneal injection leads to a significant increase in
glutamate (Smith et al., 1995). Therefore, it is possible that repeated stimulation of
cystine-glutamate exchange reduces levels of cocaine-evoked glutamate from the first
day of self-administration. It is unlikely that cystine-glutamate exchange stimulation
prevents cocaine-induced neuroplasticity by its actions at dopamine terminals. This is
based on previous findings that suggest blocking D2 (Caine et al., 2002) or D1 dopamine
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(Koob et al., 1987) receptors during self-administration either is ineffective or
exacerbates cocaine-seeking during the maintenance phase.
Cocaine-induced neuroplasticity may occur in the absence of diminished cystineglutamate exchange. By chronic stimulation of cystine-glutamate exchange during the
maintenance phase of self-administration we deduce that preventing diminished cystineglutamate exchange was the primary contributor to blocking cocaine-induced
neuroplasticity in the form of cocaine-evoked glutamate, diminished basal glutamate, and
reinstatement behavior. Most data supports that cystine-glutamate exchange regulates
synaptic glutamate (Baker et al., 2003, Moran et al., 2003, Moussawi et al., 2011a) and
dopamine as shown in this chapter. However, cocaine can alter levels of other
neurotransmitters [for review see (Torregrossa and Kalivas, 2008)]. Therefore, it is
possible that diminished cystine-glutamate exchange may be coincidental in cocaineinduced neuroplasticity. To address this, a future experiment may involve blocking
cystine-glutamate exchange during reinstatement in animals that received repeated Nacetylcysteine. If diminished cystine-glutamate exchange is central to cocaine-evoked
glutamate and reinstatement, CPG should restore levels of reinstatement to what is
observed in rats not receiving NAC during self-administration.
An alternate mechanism that may contribute to altered glutamate signaling in the
nucleus accumbens core is glutamate transport. As mentioned previously, glutamate
transporters regulate the levels of glutamate both in the extrasynaptic pool and at the
synaptic cleft (Danbolt, 2001). Interestingly, glutamate transporters are highly coupled to
cystine-glutamate exchange. For example, GLT-1 and system xc- can be expressed by the
same transcription factor, Nrf2 (Shih et al., 2003), and pharmacological agents, such as
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the -lactam antibiotic ceftriaxone, that restores expression of cystine-glutamate
exchange also restores expression of GLT-1 (Knackstedt et al., 2010). Diminished
glutamate transport by GLT-1 would also contribute to elevated cocaine-evoked
glutamate. In order to address this, an experimenter may need to determine if repeated Nacetylcysteine prevents cocaine-induced decreased GLT-1 expression.
We are particularly interested in neuroplasticity contributing to relapse
vulnerability. We hypothesized that animals exhibiting elevated cocaine-primed
reinstatement due to high-intake cocaine during the maintenance phase of selfadministration also exhibit elevated cocaine-evoked glutamate neurotransmission during
reinstatement. This approach was used because it has been previously shown that the
magnitude of behavioral output during reinstatement correlates with the amount of
cocaine intake during self-administration (Sutton et al., 2000), which is consistent with
findings presented in this chapter. Surprisingly, animals consuming elevated levels of
cocaine showed no changes in cocaine-evoked glutamate during reinstatement when
compared to low-intake animals, despite an increase in cocaine-primed reinstatement.
Increasing levels of dopamine specifically in the nucleus accumbens core is
sufficient to induce reinstatement (Spealman et al., 1999, Cornish and Kalivas, 2000,
Park et al., 2002, Shalev et al., 2002). However, blocking dopamine receptors does not
abolish cocaine-primed reinstatement (McFarland and Kalivas, 2001, Anderson et al.,
2003). Given this, we did not expect to find differences in cocaine-evoked dopamine in
animals withdrawn from low- versus high-intake self-administration conditions.
Interestingly, the cocaine-evoked extracellular dopamine response in the nucleus
accumbens was elevated in high- compared to low-intake animals. More importantly, we
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were able to reduce this augmented dopamine response by pretreatment with Nacetylcysteine, suggesting that diminished cystine-glutamate exchange may play a role in
augmented dopamine release and reinstatement in high-intake animals. Animals
withdrawn from high-intake cocaine self-administration exhibited diminished cystineglutamate exchange compared to low-intake animals. These findings suggest that
decreased system xc- activity may contribute to augmented dopamine and reinstatement
in animals with heightened relapse susceptibility.
N-acetylcysteine blunts cocaine-induced reinstatement
Stimulating cystine-glutamate exchange with the cysteine prodrug Nacetylcysteine (NAC) reduces cocaine-primed reinstatement as shown in this chapter and
previously (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008). Further, increased
glutamate neurotransmission is necessary for cocaine craving in humans (Breiter et al.,
1997, Volkow et al., 2005) and essential for reinstatement of cocaine-seeking in rodents
(Park et al., 2002, McFarland et al., 2003, Schmidt et al., 2005), therefore it may seem
counterintuitive that stimulating glutamate release through cystine-glutamate exchange is
effective in reducing cocaine-seeking as seen in this chapter. However, it is important to
be mindful of the purpose of multiple pools of extracellular glutamate. System x creleases glutamate into the extrasynaptic compartment, activating presynaptic group II
metabotropic glutamate receptors (Baker et al., 2002, Moran et al., 2005), then reducing
the release of synaptic vesicular glutamate (Moran et al., 2003, Moran et al., 2005,
Moussawi et al., 2011b) and dopamine as shown in this chapter.
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Contribution of system xc- and dopamine in the NAcc to heightened relapse vulnerability
Animals that received high levels of cocaine during self-administration (1.0
mg/kg/200L infusion, IV, 6 h/d) showed elevated levels of cocaine-evoked dopamine
when compared to animals that received lower levels (0.5 mg/kg/200L infusion, IV, 2
h/d), contrary to findings by others (Ahmed et al., 2003, Lack et al., 2008). However, in
the mentioned studies, animals underwent microdialysis within 24 hours of the final selfadministration session and in chambers that were not associated with cocaine selfadministration. This is important as it has been shown previously that drug-paired cues
contribute to cocaine-evoked dopamine (Ito et al., 2000). Therefore, it is likely that
microdialysis taken place in the self-administration chambers, such as described in this
chapter, provides a more accurate assessment of cocaine-evoked dopamine. The addiction
field would benefit by investigating the contribution of drug-associated cues to cocaineevoked drug seeking and dopamine. Interestingly, previous findings have shown that
inhibiting the ventral subiculum of the hippocampus can block cocaine-primed
reinstatement (Sun and Rebec, 2003). This is significant because the hippocampus is
highly associated with spatial cues (Baylis and Moore, 1994, 1996), making it a likely
region contributing to the differential release of dopamine in cocaine-withdrawn rats.
Animals withdrawn from high-intake conditions exhibited diminished cystineglutamate exchange compared to low-intake animals. Further, when stimulating cystineglutamate exchange in high-intake animals just prior to cocaine-primed reinstatement, the
augmented extracellular dopamine response was diminished. This suggests that
diminished system xc- activity contributes to augmented dopamine signaling in the
nucleus accumbens, as illustrated in figure 1.10, leading to elevated cocaine-seeking.
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Cocaine-evoked dopamine Cocaine-evoked dopamine
in High-intake animals
in High-intake animals
pretreated with NAC

Figure 1.10. Representative schematic depicting changes in cystine-glutamate exchange, dopamine
neurotransmission, and how treatment with N-acetylcysteine reduces augmented dopamine release.
(a) Under normal drug naïve conditions, dopamine release is tightly regulated by cystine-glutamate
exchange and group II receptors. (b) Animals withdrawn from cocaine self-administration have
diminished cystine-glutamate exchange and therefore less tone on group II receptors, disinhibiting
synaptic release of dopamine. (c) Treating cocaine-withdrawn animals with N-acetylcysteine
increases extrasynaptic glutamate and tone on group II receptors, returning dopamine release to
almost normal levels.

One possible link between augmented reinstatement and elevated cocaine-evoked
dopamine are the receptor affinities for dopamine. For example, D2-like dopamine
receptors, which are considered inhibitory because they are Gi-linked, have a higher
affinity for dopamine. This means that lower levels of dopamine stimulate primarily D2like dopamine receptors. Conversely, D1-like dopamine receptors are considered
excitatory because they are Gs-linked, and have a lower affinity for dopamine. Therefore,
it is likely that augmented extracellular dopamine is required for activation of D1-like
dopamine receptors. This is in line with findings that inactivation of D1-like or D2-like
receptors in the core individually can block cocaine-primed reinstatement [for review see
(Anderson et al., 2003, Schmidt et al., 2005, Schmidt et al., 2006)].
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By manipulating conditions that altered reinstatement behavior and cocaineinduced plasticity, we were able to support the predictive validity of self-administration
as a preclinical model for addictive behavior. The findings in this chapter suggest that
high levels of drug intake results in the emergence of drug-induced adaptations that
contribute to heightened relapse vulnerability. High-intake rats exhibit a more robust
increase in extracellular levels of nucleus accumbens dopamine, but not glutamate,
following a cocaine injection and this likely contributes to augmented reinstatement. The
results are surprising because increased extracellular glutamate, but not dopamine, in the
nucleus accumbens is necessary for cocaine-primed reinstatement (Cornish et al., 1999,
Cornish and Kalivas, 2000, Park et al., 2002, Anderson et al., 2003, McFarland et al.,
2003, Bachtell et al., 2005, Schmidt et al., 2005). In addition, diminished cystineglutamate exchange was exhibited in high-intake animals when compared to low-intake
animals. These findings also suggest that dysregulation of system xc- in high-intake
animals may be due to altered dopamine signaling. We will investigate the regulation of
cystine-glutamate exchange by dopamine receptors. But first, in chapter 2 we establish a
model for measuring regulation of system xc-.
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CHAPTER 2

Development of assays for measurement of cystine-glutamate exchange
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Introduction
Cystine-glutamate exchange by system xc- is an important regulator of synaptic
activity that is altered in neuronal disorders such as schizophrenia (Baker et al., 2008,
Lavoie et al., 2008) and cocaine addiction (Baker et al., 2003, Moran et al., 2005, Amen
et al., 2011). In order to determine how cystine-glutamate exchange is altered in diseased
states, we must first investigate how it is regulated. The aim of this chapter is to establish
in vitro and in vivo assays that allow us to efficiently measure regulation of system xc-.
Cystine-glutamate exchange stoichiometrically exchanges extracellular cystine for an
intracellular glutamate at a 1:1 ratio. We will compare the use of glutamate release and
cystine uptake as a reliable measure of cystine-glutamate exchange. We will also look to
determine the cell type from which cystine-glutamate exchange takes place in vitro. In
order to determine if we can regulate cystine-glutamate exchange in vitro, we will
attempt to modulate cystine transport by cAMP-dependent protein kinase (PKA).
Cystine-glutamate exchange contributes to neuronal dopamine signaling in the nucleus
accumbens core. In order to use mixed cultures from the cortex, we attempt to show that
there is similar regulation of neuronal signaling in the cortex as is found in the
accumbens.
Others have used glutamate transport to measure cystine-glutamate exchange
activity (Knackstedt et al., 2010); the advantage to this method is the availability and
stability of [3H]glutamate when compared to cystine. This requires that the experimenter
distinguish between Na+-dependent and Na+-independent uptake. While cystine is
primarily transported by system xc- (Murphy et al., 1989), glutamate can be transported
both through system xc- and system XAG. In order to distinguish system xc- from system
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XAG transport, the experimenter must utilize Na+-free media, an unacceptable condition
when attempting to regulate cystine-glutamate exchange through receptor stimulation and
kinase activity. This chapter will show that the use of [14C]cystine transport in vitro is a
preferable model for measuring cystine-glutamate exchange activity.
System xc- is composed of two proteins, the nonspecific 4f2hc heavy chain
subunit, and the functional xCT subunit. xCT has consensus phosphorylation sites and
has previously been shown regulated by PKA and PKC (Baker et al., 2003, Tang and
Kalivas, 2003). In this chapter, we support these findings using in vitro methods utilized
in chapters 3 and 4.
Cystine-glutamate exchange regulates synaptic activity in vivo (Baker et al., 2002)
and in slice preparation from the nucleus accumbens (Moran et al., 2005, Moussawi et
al., 2011b). In vitro studies in this dissertation are performed in cortical cultures. In this
chapter, we present data suggesting cystine-glutamate exchange regulates
neurotransmission in the cortex as well, supporting the use of cortical cultures in future
studies.

Materials and Methods
Animals
Animal housing conditions and experimental protocols were approved by the
Marquette University Institutional Animal Care and Use Committee and carried out
according to the NIH Guide for the Care and Use of Laboratory Animals (revised 1996).
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Mouse cortical cultures
Mixed cortical cell cultures containing glial and neuronal cells were prepared
from fetal (15–16 day gestation) mice as previously described (Lobner, 2000).
Dissociated cortical cells were plated on 24-well plates coated with poly-D-lysine and
laminin in Eagles’ Minimal Essential Medium (MEM, Earle’s salts, supplied glutaminefree) supplemented with 5% heat-inactivated horse serum, 5% fetal bovine serum, 2 mM
glutamine and glucose (total 21 mM). Astrocyte enriched glial cultures were prepared as
described for mixed cultures except they are from cortical tissue taken from post-natal
day 1–3 mice (Choi et al., 1987, Schwartz and Wilson, 1992). Neuronal cultures were
prepared as described for mixed cultures with cytosine arabinoside (10 μM) added to the
cultures 48 h after plating to inhibit glial replication. Less than 1% of cells in these
cultures stain for glial fibrillary acidic protein (GFAP) (Dugan et al., 1995). Cultures
were maintained in humidified 5% CO2 incubators at 37 °C. Mice were handled in
accordance with a protocol approved by our institutional animal care committee and in
compliance with the Public Health Service Policy on Humane Care and Use of
Laboratory Animals. All efforts were made to minimize animal suffering and reduce the
number of animals used.
C6 glioma cell cultures
C6 glioma cells (ATCC, Manassas, VA) were grown and propagated in F-12K
medium supplemented with 10% heat inactivated fetal bovine serum in 25cm2 tissue
flasks. For in vitro cystine uptake experiments, cells were lifted with trypsin (0.25%
trypsin/0.53mM EDTA in HBSS), and plated in poly-lysine coated 24-well tissue culture
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plates at a density of ~2 to 3x105 cells/well. Cells were allowed to grow to confluence
(~3 DIV) prior to testing for cystine uptake.
Acute regulation of cystine uptake in vitro
All experiments were performed in a 37ºC bath. As illustrated below, cells were
washed 3x with 1mL warm HEPES buffered saline solution, vacuumed to 150 L, and
250L of the drug was added to bring to the indicated concentration. Cells incubated for
20 minutes with the drug, then a small aliquot, 10 L, of HEPES buffered saline solution
was added that brought the concentration of [14C]cystine (Perkin Elmer, Waltham, MA)
and TBOA to 1 M and 10 M, respectively. Cells incubated for another 20 minutes.
The uptake experiment was rapidly terminated by wash 3x with 1mL of ice-cold PBS,
vacuumed dry, and 500 L 0.1% SDS added to solubilize the cells. Resultant lysate was
analyzed by scintillation counter and counts were normalized to the mean of the control
group.
3x wash and drug
application

Cystine application

20 minutes

3x ice-cold PBS wash, and
solubilize
20 minutes

Time Dependent Glutamate Release in vitro
C6 glioma cells cultured as mentioned above were washed 3x with 1mL HEPES
buffered saline solution. 10L aliquots were collected at 0, 2.5, 5, 10, 20, 40, 80, and 160
minute increments. Each aliquot was measured for glutamate content by HPLC.
Time Dependent Cystine Uptake in vitro
C6 glioma cells cultured as mentioned above were wash 3x with 1mL HEPES
buffered saline solution and [14C]cystine (1M) was added to the media. Cells were
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washed 3x with 1mL ice-cold PBS, solubilized with 500L 0.1% SDS, and measured for
cystine by scintillation counter at 0, 2.5, 5, 10, 20, 40, 80, or 160 minutes.
Quantification of Glutamate
The concentration of glutamate in culture was quantified by comparing peak
heights from samples and external standards using HPLC coupled to fluorescence
detection. Precolumn derivatization of glutamate with opthaldehyde was performed using
a Shimadzu LC10AD VP autosampler. The mobile phase consisted of 13% acetonitrile,
100 mM Na2HPO4, and 0.1 mM EDTA, pH 5.90. Glutamate was separated using a
reversed-phase column (4 μm; 140 × 6.0 mm; Phenomenex, Torrance, CA), and detected
using a Shimadzu 10RF-AXL fluorescence detector with excitation and emission
wavelengths of 320 and 400 nm, respectively.
Quantification of Dopamine
Dopamine concentrations were quantified by comparing peak heights from
samples and external standards using HPLC coupled to electrochemical detection. The
mobile phase consisted of 15% acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM
citric acid, 3 mM SDS, and 50 μM EDTA, pH 5.6. Dopamine was separated using a
reversed-phase column (3 μm; 80 × 3.2 mm; ESA Inc., Bedford, MA) and detected using
an ESA Coulochem II detector coupled to two electrodes set at −0.075 V and +0.25 V,
respectively.
Prefrontal cortical surgery
Male Sprague–Dawley rats (Harlan, Indianapolis, IN) weighing 300–350 g were
individually housed in a temperature-controlled colony room with a 12-h light/dark cycle
with food and water available ad libitum. The housing conditions and care of the rats was
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in accordance with the Animal Welfare Act, and all procedures were approved by the
Marquette University IACU Committee. Rats included in the microdialysis studies were
anesthetized using pentobarbital (50 mg/kg, IP) with atropine sulfate (1 mg/kg, IP)
pretreatment to limit tracheobronchial secretions. Bilateral guide cannula (20 gauge,
14 mm; Plastics One, Roanoke, VA) were implanted using coordinates (+3.1 mm anterior
and ±1.0 mm mediolateral to Bregma, and −0.75 mm ventral from the surface of the skull
at a 6° angle from vertical) derived from (Paxinos and Watson, 1986). Rats were then
given at least 5 days to recover from surgery prior to testing.
In Vivo Microdialysis
Microdialysis experiments were conducted as described previously (Baker et al.,
2008). Briefly, removable probes were inserted through the guide cannulae into the
prefrontal cortex. The next day, dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM
CaCl2, 1.2 mM MgCl2, and 0.15% phosphate-buffered saline, pH 7.4) was pumped
through the probes at 1 μl/min for at least 3 h; afterwards 20 min samples were collected
before and after treatment with N-acetylcysteine (90mg/kg, IP). Dopamine concentrations
were quantified by comparing peak heights from samples and external standards using
HPLC coupled to electrochemical detection. The mobile phase consisted of 15%
acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM citric acid, 3 mM SDS, and 50
μM EDTA, pH 5.6. Dopamine was separated using a reversed-phase column (3 μm; 80 ×
3.2 mm; ESA) and detected using an ESA Coulochem II detector coupled to two
electrodes set at −0.075 V and +0.25 V, respectively.
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Histology
Rats included in the microdialysis studies were given an overdose of pentobarbital
(60 mg/kg, IP), and the brains were fixed by intracardiac infusion of 0.9% saline
followed by 2.5% formalin solution. Brains were removed and stored in 2.5 % formalin
for at least seven days prior to sectioning. The tissue was then blocked and coronal
sections (100 μm) were cut and stained with cresyl violet to verify probe placements.
Statistical analyses
SPSS software (version 16) was used to perform the statistical analyses. When
comparing between two treatments, a Student’s t test was performed. Two way analysis
of variance (ANOVA) was used with more than one between subject factors. Data
collected over time were analyzed using analysis of variance (ANOVA) with
sulfasalazine as a between subjects measure and time (20-min interval) as a repeated
factor. Post hoc comparisons were conducted using t-tests when only two data points
were compared, or with Tukey HSD with multiple data points.
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Results
Differential cystine uptake in neurons and glia in culture
Figure 2.1 illustrates the differential uptake of cystine in primary mouse cortical
culture. Pure neurons or pure glia were cultured and [14C]cystine transport was measured.
A two-way ANOVA with cell type and treatment as between subjects factors revealed a
significant main effect of cell type
(F1,63=139.045, p<0.001), treatment
(F3,63=79.043, p<0.001), and a
significant interaction between the two
(F3,63=43.311, p<0.001). The cystine
glutamate exchange inhibitor (S)-4carboxyphenylglycine was used to
Figure 2.1. System xc- is expressed primarily on
astrocytes. Primary mouse cortical cells were
cultured for two weeks and measured for cystine
uptake in the presence or absence of the cystineglutamate
exchange
inhibitor
(S)-4carboxyphenylglycine (CPG) or the system X AG
inhibitor D-aspartate. A two-way ANOVA with cell
and treatment as between subjects factors reveal a
significant main effect of cell culture (F1,63=139.045,
p<0.001), treatment (F3,63=79.043, p<0.001), and a
significant
interaction
between
the
two
(F3,63=43.311, p<0.001). *Significant difference
from control.

determine the system xc- specific portion
of uptake, and D-aspartate was used to
determine the system XAG-specific
portion of uptake. Post hoc analyses
with treatment as a variable in neuronal
culture yielded significant contributions

of CPG-dependent uptake (ANOVA: F3,31=20.193, p<0.001; Tukey HSD p<0.001) and
D-aspartate-dependent uptake (Tukey HSD, p<0.001). Interestingly, post hoc analyses
with treatment as a variable in glial culture revealed significant contributions of CPGdependent uptake (ANOVA: F3,31=69.105, p<0.001; Tukey HSD, p<0.001), but not for
D-aspartate-dependent uptake (Tukey HSD, p=0.120).
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Cystine transport as a valid model for measuring cystine-glutamate exchange
The above experiments indicate that glia, likely astrocytes, is the primary cell type
expressing cystine-glutamate exchange. Further, neurons express multiple sources of
cystine transport in addition to system xc-. C6 glioma cells were utilized in the following
experiments because they express high levels of cystine-glutamate exchange with
diminished system XAG (Ye et al., 1999).
These cells were used to determine if
glutamate release or cystine transport is
the optimal measure of system xc- activity.
Figure 2.2 illustrates that glutamate
accumulates in the media over time even
in the absence of exogenous cystine. A
two-way ANOVA with time (0 – 160 min)
Figure 2.2. Cystine-glutamate exchange as
assessed by the measurement of extracellular
glutamate. C6 glioma cells were cultured, washed
with HEPES buffered saline solution, and either
measured for extracellular glutamate. In the
presence of the cystine-glutamate exchange
inhibitor sulfasalazine (0 or 500M), glutamate
release was significantly different for the 10, 80,
and 160 minute time points. *Significant
difference from SSZ treated (t test, p<0.05).

as a repeated measure and SSZ as between
subjects factors yielded significant main
effects of time (F7,47=144.808, p<0.001),
SSZ (F1,47=27.483, p<0.001), as well as a

significant interaction (F7,47=6.416, p<0.001). Post hoc analyses reveal that there was a
significant increase in glutamate release in the absence of cystine at multiple time points
(Tukey HSD, p<0.05). This was not significantly altered by the inhibition of system xc(i.e., SSZ) (Tukey HSD, p<0.001) indicating that most of the glutamate accumulating in
the media is not due to cystine-glutamate exchange. These data demonstrate that one
issue with measuring glutamate to reflect system xc- is that this approach is influenced by
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other mechanisms contributing to
glutamate homeostasis, and this may
present signal-noise concerns.
Figure 2.3 illustrates that
[14C]cystine (1M) transport significantly
increased over time. A two way ANOVA
with time and SSZ as between subject
Figure 2.3. Cystine-glutamate exchange as
assessed by the measurement of uptake of
radiolabeled cystine. C6 glioma cells were
cultured, washed with HEPES buffered saline
solution, and measured for [14C] cystine uptake.
In the presence of the cystine-glutamate exchange
inhibitor sulfasalazine (0 or 500M), cystine
transport was significantly different at most of the
time points. *Significant difference from SSZ
treated (t test, p<0.05).

factors yielded significant main effects of
time (F7,44=625.350, p<0.001), SSZ
(F1,44=1841.993, p<0.001), as well as a
significant interaction (F7,44=401.081,
p<0.001). Further, at 20 minutes, there

was a significant difference, when compared to 0 minutes, in cystine uptake in the
absence (Tukey HSD, p<0.05) but not the presence (Tukey HSD, p=0.846) of SSZ, as
well as a significant difference between the two at 20 minutes (t4=11.145, p<0.001).
Given that cystine transport was significantly diminished in the absence of cystineglutamate exchange (i.e. in the presence of SSZ), these findings suggest that cystine
transport is a more reliable measure of cystine-glutamate exchange in culture.
Cystine-glutamate exchange in vitro is regulated by protein kinase A (PKA)
Previous studies have shown that cystine-glutamate exchange can be regulated by
PKA in tissue punches (Baker et al., 2003) and in vitro (Tang and Kalivas, 2003). Our
next goal was to determine whether a similar regulation occurs in C6 cells, in part to
evaluate the suitability of using these cells to study the regulation of system xc- activity.
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Figure 2.4 illustrates regulation of
cystine-glutamate exchange in vitro as
measured by [14C]cystine uptake in C6
glioma cells. Cystine transport was
unaffected by stimulating protein kinase
A (PKA) activity with the cAMP analog
Figure 2.4. PKA regulates cystine-glutamate
exchange in culture. C6 glioma cells were grown in
culture and pretreated for 20 minutes with drugs
that regulate PKA activity. Stimulating PKA with
Sp-cAMPS had no significant effect on cystine
transport (100M; t29=0.8100, p=0.425). Inhibiting
PKA with H89 decreased cystine transport (10M;
t6=0.2.4050, p=0.05), as well as with the more
specific PKA inhibitor KT 5720 (100nM;
t6=3.0200, p<0.05). *Significant difference from
control (t test, p<0.05).

Sp-cAMPS (0 or 100 M; t29=0.8100,
p=0.425). Interestingly, inhibiting PKA
with H89 (0 or 10M) showed a
significant decrease in cystine uptake
(10M; t6=0.2.4050, p=0.05). We also

examined the effect of KT5720, a more potent and selective allosteric inhibitor of PKA.
KT5720 significantly decreased cystine transport (0 or 100nM; t6=3.0200, p<0.05). The
drug concentrations used were based on previous publications for their use in vitro: SPcAMPS (Song et al., 2006, Zhang et al., 2009, Zhang et al., 2010), H89 (Park et al.,
2009), and KT572 (Russo et al., 2009). The lack of an effect of Sp-cAMPs creates
concerns regarding the utility of using C6 cells to study the regulation of system xc-.
Cystine-glutamate exchange regulates dopamine signaling in the cortex
An alternative to using C6 cells is to use cortical cultures (Liu et al., 2009, Liu et
al., 2011, Rush et al., 2012). Interestingly, similar to ex vivo punches (Baker et al., 2003),
system xc- activity in these cells are also regulated by PKA (Tang and Kalivas, 2003),
thereby supporting the use of these cells for the study of system xc-. Because these cells
are harvested from a region other than the nucleus accumbens, we sought to determine
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whether system xc- in the cortex regulates neurotransmission in this region in a manner
that is similar to the nucleus accumbens. To do this, we examined the impact of the
cysteine prodrug N-acetylcysteine on dopamine signaling. The reason for sampling
dopamine rather than glutamate is that
extracellular dopamine levels are known
to be entirely neuronal in nature, thereby
providing a more clear assessment of the
synaptic activity. Figure 2.5 illustrates
that stimulating cystine-glutamate
exchange with N-acetylcysteine (NAC;
90 mg/kg, IP) decreased extracellular
dopamine levels in the prefrontal cortex
in vivo; a finding that is similar to what

Figure 2.5. Stimulating cystine-glutamate
exchange decreases dopamine in the prefrontal
cortex. Acute treatment with N-acetylcysteine
(90mg/kg, IP) decreases extracellular dopamine
in the prefrontal cortex. A repeated measures
ANOVA yielded a significant effect of time
(F8,24=6.609, p<0.001). *Significant difference
from last baseline sample (Tukey HSD, p<0.05).

we have observed in the nucleus accumbens. A repeated measures ANOVA yielded a
significant effect of time (F8,24=6.609, p<0.001), suggesting cystine-glutamate exchange
regulates neurotransmission in the cortex.

Discussion
The aim of this chapter was to determine the cell type and substrate for measuring
cystine-glutamate exchange in vitro. Primary mouse cortical cultures, both pure neuronal
and pure glial, were measured for [14C]cystine uptake. The majority of cystine transport
occurred in astrocytes as opposed to neurons. In addition, neurons expressed transport by
system XAG and system xc-, whereas astrocytes only expressed transport by system xc-.
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These findings suggest that cystine-glutamate exchange is expressed primarily on
astrocytes, and that these cells maintain a cleaner measure of system xc- activity per
measure of protein in culture.
The C6 glioma cell line was utilized due to the fact that these cells express
cystine-glutamate exchange but have decreased glutamate transporter function (Ye et al.,
1999). We chose to measure glutamate release in the absence of exogenous cystine and
found that extracellular glutamate increased both in the presence and absence of cystineglutamate exchange despite application of exogenous cystine, suggesting that an alternate
mechanism contributes to the accumulation of glutamate. One possible contribution to
extracellular glutamate is glutathione cycling. When glutathione is released, it is
metabolized into its amino acid components, among them glutamate and cysteine, which
can be auto-oxidized into cystine. However, the primary source of intracellular cystine,
the rate limiting step to glutathione synthesis, is cystine-glutamate exchange (Kranich et
al., 1998). Therefore, blockade of cystine-glutamate exchange by sulfasalazine should
inhibit increases in glutamate by glutathione cycling. Future experiments should
investigate the source of extracellular glutamate.
We found that [14C]cystine uptake significantly increase over time in a cystineglutamate dependent manner. Important to note is that glutathione cycling may also
contribute to confounds in cystine transport experiments. For example, as mentioned
previously, cystine that is transported into the cell is utilized to form glutathione. This
glutathione is then released via MRP-1, which could result in an underestimate of the
total amount of cystine-glutamate exchange Therefore, it is important to utilize the
shortest time possible to isolate the functional assay to cystine-glutamate exchange.
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An important question regarding the utility of using C6 cells to learn about the
regulation of system xc- in vivo is the degree to which we can replicate in C6 cells what
is known about in vivo system xc- regulation. To do this, we examined the impact of
increasing PKA activity since this has been shown to regulate cystine-glutamate
exchange in ex vivo punches as well as mixed cortical cultures (Baker et al., 2003, Tang
and Kalivas, 2003). Stimulating protein kinase A (PKA) activity was unable to alter
cystine transport. There are at least two interpretations of this data set. The first is that
these cells exhibit tonic PKA activity at a level that is not observed in vivo or in primary
cultured cells. Alternatively, this could indicate that PKA does not modulate system xcactivity in C6 cells. Interestingly, our results indicate that system xc- activity was
increased in C6 cells following the activation of PKA, which supports the former
interpretation. Regardless, either interpretation would indicate differential regulation of
system xc- in C6 cells relative to either primary cultures or ex vivo tissue punches. This
greatly detracts from the utility of these cells for the experiments in this thesis. Therefore,
for future studies we utilized primary cultures.
Mixed cortical cultures are a common model for measuring regulation of cystineglutamate exchange (Jackman et al., 2010, Liu et al., 2011, Rush et al., 2012). However,
we are particularly interested in system xc- in the nucleus accumbens core, given deficits
in cystine-glutamate exchange in the nucleus accumbens core contribute to cocaineseeking (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008, Knackstedt et al., 2010,
Moussawi et al., 2011b). Therefore, we wanted to determine if cystine-glutamate
exchange regulates neurotransmission in the cortex as it does in the nucleus accumbens.
Figure 2.4 illustrates that stimulating cystine-glutamate exchange decreases extracellular
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dopamine in the prefrontal cortex. This finding, coupled with previous demonstration that
cystine-glutamate exchange by system xc- is maintained by PKA and PKC in mixed
cortical culture (Tang and Kalivas, 2003), suggests that we should be able to measure
regulation by neurotransmitter signaling in this culture. Cystine-glutamate exchange by
system xc- has previously been shown tonically regulated by a number of growth factors
including interleukin-1 (Jackman et al., 2010) and fibroblast growth factor-2 (Liu et al.,
2011) in addition to acute regulation by protein kinase A (Baker et al., 2003) and protein
kinase C (Tang and Kalivas, 2003). This reveals potential regulation by neurotransmitters
that are linked to PKA or PKC, such as dopamine. Because we are interested specifically
in changes that may account for reduced activity following repeated cocaine, in the
following chapter we investigate regulation of cystine-glutamate by dopamine signaling.

66

CHAPTER 3

Regulation of system xc- by dopamine

67

Introduction
Extrasynaptic glutamate is a pool of extracellular glutamate contributed to by
astrocytic mechanisms such as cystine-glutamate exchange by system xc- that regulates
neurotransmission (Baker et al., 2002). Cystine-glutamate exchange is altered in multiple
disorders including schizophrenia (Baker et al., 2008, Lavoie et al., 2008, Dean et al.,
2009, Dean et al., 2010, Dean et al., 2011) and addiction (Baker et al., 2003, Moran et al.,
2005, Kau et al., 2008, Moussawi et al., 2011b). Interestingly, both disorders are
considered hyperdopaminergic disorders based on their association with dopamine
neurotransmission and altered behavior. This raises the possibility that system xc- is
regulated by dopamine.
Previous findings suggest that cystine-glutamate exchange is regulated by PKA
and PKC (Baker et al., 2003, Tang and Kalivas, 2003). Interestingly, dopamine receptors
are G-protein coupled (Beaulieu and Gainetdinov, 2011). Particularly, D2-like dopamine
receptors are Gi- and D1-like dopamine receptors are Gs-coupled, which means
stimulating leads to respective inactivation and activation of PKA. The aim of this
chapter is to determine if dopamine receptor signaling regulates cystine-glutamate
exchange. We examine the regulation of system xc- by dopamine, nonspecific dopamine
agonists, D1-like, and D2-like dopamine receptor agonists. We hypothesize that D1-like
dopamine receptors increase, and D2-like dopamine receptors decrease cystine-glutamate
exchange activity based on their respective activation and inactivation of PKA activity.
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Materials and Methods
Animals
These experiments utilized male and female Sprague Dawley rats (Harlan,
Indianapolis, IN). Female rats arrived at 14 days gestation. Rats were individually housed
in a temperature-controlled colony room with a 12-h reversed light/dark cycle. Housing
conditions and experimental protocols were approved by the Marquette University
Institutional Animal Care and Use Committee and carried out according to the NIH
Guide for the Care and Use of Laboratory Animals (revised 1996).
Rat mixed cortical cultures
Mixed cortical cell cultures containing glial and neuronal cells from rats were
prepared from fetal (15–16 day gestation) rats as previously described (Lobner, 2000),
with some exceptions. Dissociated cortical cells were plated on 24-well plates coated
with poly-D-lysine and laminin at a density of ~6x105 cells/well in Neurobasal medium
supplemented with 10% fetal bovine serum and 1% Glutamax-I (Life Technologies).
Cultures were maintained in humidified 5% CO2 incubators at 37 °C. All efforts were
made to minimize animal suffering and reduce the number of animals used.
Acute regulation of cystine-glutamate exchange in vitro
All experiments were performed in a 37ºC bath. As illustrated below, cells were
washed 3x with 1mL warm HEPES buffered saline solution, vacuumed to 150 L, and
250L of the drug was added to bring to the indicated drug concentration. Cells
incubated for 20 minutes with the drug, then a small aliquot, 10 L, of HEPES buffered
saline solution was added that brought the concentration of [14C]cystine (Perkin Elmer,
Waltham, MA) and TBOA to 1 M and 10 M, respectively. Cells incubated for another
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20 minutes. The uptake experiment was rapidly terminated by wash 3x with 1mL of icecold PBS, vacuumed dry, and 500 L 0.1% SDS added to solubilize the cells. Resultant
lysate was analyzed by scintillation counter and counts were normalized to the mean of
the control group.
3x Wash and drug
application

Cystine application

3x ice-cold PBS wash, and
solubilize

20 minutes

20 minutes
Regulation of cystine-glutamate exchange ex vivo

As illustrated below, tissue punches (1.25 mm diameter; Stoelting, Wood Dale,
IL) were collected from the nucleus accumbens core (figure 1.4) and incubated at 37°C
for ∼30 min on a nylon mesh platform, submerged beneath 2 mm of standard buffer
(Lobner and Lipton, 1993); the standard buffer contained 124 mM NaCl, 3.0 mM KCl,
1.4 mM KH2PO4, 1.3 mM MgSO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 4 mM glucose,
equilibrated with 95% O2, 5% CO2, pH 7.4. After a 20 min wash, the tissue was
incubated for 20 min in standard buffer containing dopamine, SKF38393, or
apomorphine and the cystine-glutamate exchange blocker sulfasalazine (0 or 500 M).
The tissue was transferred to standard buffer containing the drug treatment, [14C]cystine
(1 M), and DL-TBOA (10 M) to prevent uptake via XAG. After 20 min incubation, the
tissue punches were washed four times in ice-cold PBS and dissolved in 250 μl of 1%
SDS. One aliquot (175 μl) was used to measure [14C]cystine uptake by scintillation
counting; a second aliquot (50 μl) was used to assess protein content by the BCA method.
Wash and
solubilize
Tissue extraction
Drug application
Drug and Cystine
20 minute
equilibration

20 minutes

20 minutes
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Statistical analyses
SPSS software (version 16) was used to perform the statistical analyses. When
comparing between two treatments, a Student’s t test was performed. Two way analysis
of variance (ANOVA) was used with more than one between subject factors (such as
SCH23390 and intake condition). Experiments with multiple concentrations of one
treatment utilized ANOVA. Post hoc comparisons were conducted using t-tests when
only two data points were compared, or with Tukey HSD with multiple data points.
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Results
D2-like dopamine receptors do not regulate cystine-glutamate exchange in vitro
PKA regulates cystine-glutamate exchange ex vivo (Baker et al., 2003) and in
vitro (Tang and Kalivas, 2003). In chapter 2, we showed that inhibiting PKA activity in
vitro decreased system xc- activity. D2-like dopamine receptors are Gi-coupled and
therefore decrease adenylyl cyclase and
PKA activity (Beaulieu and Gainetdinov,
2011). We examined the ability of D2-like
receptors to decrease cystine-glutamate
exchange. Figure 3.1 illustrates that the
selective D2 receptor agonist quinpirole (0
Figure 3.1. D2 receptor stimulation did not
regulate cystine-glutamate exchange in vitro.
Primary rat mixed cortical cultures were made
from embryonic dissection (E15-E17) and
cultured for 14 days. Pretreatment with the
selective D2 agonist quinpirole (0 – 100M)
yielded no significant change in [14C]cystine
uptake (F5,47=0.500, p=0.774).

– 100M) was unable to alter [14C]cystine
transport in rat mixed cortical cultures
(ANOVA: F5,47=0.500, p=0.774). Drug
concentrations were selected based on

previous findings (Li et al., 2006, Guo et al., 2010). Quinpirole was selected due to its
affinity for D2-like versus D1-like dopamine receptors (Km = 4.8nM for D2 and 1.9M
for D1) over other available agonists such as bromocriptine (Km = 8nM for D2 and
440nM for D1).
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Regulation of cystine-glutamate exchange by D1-like dopamine receptors
We also examined the ability of
Gs-coupled D1-like dopamine receptors
to regulate cystine-glutamate exchange.
Figure 3.2 illustrates regulation of
cystine-glutamate exchange by D1dopamine receptors in vitro. Acute
application of SKF38393 (0 – 1M)
14

increased [ C]cystine transport in mixed
cortical cultures from rat (ANOVA:
F3,39=3.587, p<0.05). Post hoc analyses
show a significant effect of SKF38393 at

Figure 3.2. D1 dopamine receptor stimulation
increased cystine-glutamate exchange in vitro.
Primary rat mixed cortical cultures were made from
embryonic dissection (E15-E17) and cultured for
14 days. Pretreatment with the D1 agonist
SKF38393 (0 – 1M) significantly increased
[14C]cystine
uptake
(F3,39=3.587,
p<0.05).
*Significant difference from control (Tukey HSD,
p<0.05).

the 0.1 M concentration (Tukey HSD, p<0.05). The concentration of SKF38393 was
selected based on previous findings
(Dumont et al., 2004, Gomes et al., 2004).
Cystine-glutamate exchange by
system xc- is diminished in the nucleus
accumbens core of animals withdrawn
from chronic cocaine. Therefore, we
Figure 3.3. The D1 agonist SKF38393 does not
increase cystine transport in the nucleus
accumbens core ex vivo. 1mm x 1mm tissue
punches from the nucleus accumbens core were
extracted from drug naïve animals and incubated
in slice buffer, pretreated with SKF38393 (0 or
100nM), then treated with SKF38393 and
[14C]cystine (1M). A t-test yielded no
significant effect of drug (t9=0.450, p=0.664).

wanted to determine of D1-like dopamine
receptors regulate cystine-glutamate
exchange in ex vivo tissue punches from
the nucleus accumbens core. Figure 3.3
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illustrates lack of regulation by SKF3839 (0
or 100nM) ex vivo (t test, t9=0.450,
p=0.664). One explanation for this finding
is that there may be differences in
dopamine receptor-dependent regulation of
system xc- between primary cultures and ex
vivo punches. The nature of the difference
may be in terms of drug potency indicating
that either higher or lower concentrations of
SKF38393are needed to fully evaluate the
Figure 3.4. Nonspecific dopamine receptor
stimulation did not regulate cystine-glutamate
exchange in the nucleus accumbens core ex vivo.
Tissue punches from the rat nucleus accumbens
core were pretreated with (a) dopamine (0 –
300nM), (b) apomorphine (0 – 10M), None of
which had a significant effect on [14C]cystine
transport.

effect of D1-like receptors on system xcactivity in ex vivo punches. Alternatively,
the differences may be more substantive
indicating differential regulation at the

level of the receptor, which could complicate the interpretation of even the D2 data.
Given that the rational for these experiments stems from the hypothesis that dopamine
may regulate system xc-, additional characterization involved ex vivo punches and
dopamine.Figure 3.4a illustrates that dopamine was not capable of altering cystineglutamate exchange in ex vivo tissue punches from the nucleus accumbens core. We did
observe a non-significant trend, suggesting that we were not able to fully stimulate
dopamine receptors. There are two interpretations of this data set. First, dopamine may
exert mild, insignificant effects on system xc- activity. Alternatively, the modest effect
may be due to the elimination of dopamine since dopamine can be cleared by organic
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cation transporters (OCT-3) and dopamine transporters (DAT) or inactivated by oxidation
and metabolism by monoamine oxidase. Therefore, we looked at nonspecific stimulation
of dopamine receptors by apomorphine, which would not be cleared or eliminated in a
manner that may complicate the interpretation of the dopamine experiment. Figure 3.4b
illustrates that apomorphine was not capable of altering cystine-glutamate exchange. The
concentration of apomorphine used was based on previous findings eliciting effects in
astrocytes (Li et al., 2006). ANOVAs run for [14C]cystine transport yielded no
significant effect of dopamine (3.4a; 0 – 300nM; F3,33=2.014, p=0.131) or apomorphine
(3.4b; 0 – 10M; F3,28=0.734, p=0.542).

Discussion
The aim of this chapter was to determine if diminished cystine-glutamate
exchange during withdrawal from cocaine self-administration can be attributed to altered
dopamine signaling (Bradberry and Roth, 1989, Xia et al., 1992, Cerruti et al., 1994, De
Vries et al., 1999, Alleweireldt et al., 2002, Bachtell et al., 2005, Ben-Shahar et al.,
2007). Cystine-glutamate exchange has previously been shown regulated by protein
kinase A (Baker et al., 2003, Tang and Kalivas, 2003). D2-like dopamine receptors are
linked to Gi signaling, decreased adenylyl cyclase activity, and cAMP production [for
review see (Missale et al., 1998)]. Therefore, we hypothesized that D2 dopamine receptor
stimulation would decrease cystine-glutamate exchange activity. Contrary to our
expectations, the selective D2-like dopamine receptor agonist quinpirole was
unsuccessful at altering cystine transport in vitro. This finding was surprising giving that
others have shown regulation of cystine-glutamate exchange by receptors also linked to
Gi, such as Group II metabotropic glutamate receptors (Xi et al., 2002a). In the

75

mentioned publication, stimulating and inhibiting Group II receptors decreased and
increased, respectively, extracellular glutamate in the nucleus accumbens in a cystineglutamate exchange dependent manner. Aside from targeting D2 receptors, our
experiment differs in that it was performed in mixed cortical culture. A likely explanation
for the lack of regulation of cystine-glutamate exchange by D2-like receptors is the level
of expression of these receptors in the developing central nervous system. In particular,
previous studies have suggested that in the developing rat cerebral cortex, D2 receptor
expression does not reach maximal levels until postnatal day 35 (Tarazi and Baldessarini,
2000). In this study, they showed that postnatal day 14, similar to the age of the mixed
cortical culture, rat showed no significant increase in D2 receptor expression than day 7.
We examined regulation of cystine-glutamate exchange by D1-dopamine
receptors. D1-like dopamine receptors are coupled to Gs, and therefore activate
PKA,leading us to hypothesize that targeting D1-like dopamine receptors would regulate
system xc- activity. Stimulating D1-like dopamine receptors in vitro significantly
increased cystine transport, suggesting that D1-like dopamine receptors regulate cystineglutamate exchange. Cystine-glutamate exchange by system xc- is diminished in the
nucleus accumbens core of animals withdrawn from chronic cocaine. Therefore, we
wanted to determine of D1-like dopamine receptors regulate cystine-glutamate exchange
in ex vivo tissue punches from the nucleus accumbens core. The D1 dopamine receptor
agonist, SKF38393 did not alter cystine transport in the nucleus accumbens core ex
vivo.The fact that D1-like receptor stimulation regulated cystine-glutamate exchange in
vitro but not in tissue punches from the nucleus accumbens core is likely attributed to a
number of differences between the systems. In vitro cultures were acquired from the
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cortex, whereas the tissue punches are from the nucleus accumbens. Further, in vivo
tissue punches were acquired from adult males, whereas the culture system originally
derives from embryonic day 16, and are utilized 14 days later. Receptor expression and
signaling develops over time in the rat. For example, GABA receptors act in a more
stimulatory manner in early development due to elevated internal chloride concentrations
in immature neurons (Pfeffer et al., 2009) and NMDA receptor subunit expression
changes through early development (Wenzel et al., 1997). As with D2 receptors in the
developing rat cortex, D1 receptor expression does not reach its maximum until at least
postnatal day 60, which postnatal day 14 at significantly lower levels (Tarazi and
Baldessarini, 2000). However, though there was no direct comparison between D1 and
D2 receptors, the data presented in this publication suggest a higher expression of D1
receptors over D2 receptors; a potential reason for regulation of cystine-glutamate
exchange by D1, but not D2 receptors in mixed cortical culture.
In tissue punches, afferent fibers are dissected out, leaving only cell bodies from
the region from which the tissue was taken and removing synaptic signaling. Conversely,
in mixed cortical culture neuronal signaling remains intact, revealing the possibility that
D1-like receptor activation occurred on the cortical neurons, leading to release of
neuronal signaling that may act on astrocytes. Cortical neurons, such as glutamatergic,
project to the nucleus accumbens. Therefore it is possible that cortical activation, perhaps
by D1-like dopamine receptor stimulation, may lead to downstream regulation of cystineglutamate exchange in the nucleus accumbens. In support of this, previous investigators
have found that a single activation of the prefrontal cortex can restore basal glutamate by
cystine-glutamate exchange in the nucleus accumbens of cocaine-withdrawn animals
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(Berglind et al., 2009). While we can report that stimulation of D1-like receptors in the
nucleus accumbens core was unable to regulate cystine-glutamate exchange, it is possible
that dopamine in the prefrontal cortex regulates cystine-glutamate exchange in the
nucleus accumbens core. To address this, similar to previous experiments (Berglind et al.,
2009), future studies should attempt to stimulate D1-like receptors in the prefrontal
cortex and measure cystine-glutamate exchange in vivo. Predicted findings are likely that
stimulation would lead to an increase in basal glutamate. Alternatively, it is possible that
basal cystine-glutamate exchange is difficult to elevate in vivo. In that instance, one may
consider attempting to restore cocaine-induced diminished cystine-glutamate exchange
by stimulation of D1-like receptors in the prefrontal cortex.
Our assumption is that regulation by dopamine is dependent on dopamine
receptor activation, yet in this system, it may result from non-receptor mediated actions.
For example, cystine-glutamate exchange can be upregulated in the presence of oxidative
stress (Allen et al., 2002, Dun et al., 2006, Lewerenz et al., 2006). Further, dopamine can
induce oxidative stress either by auto-oxidation into dopamine quinones (LaVoie and
Hastings, 1999) or by eventual formation of cysteinyl-dopamine (Rabinovic and
Hastings, 1998). Thus, there may be alternate possibilities for dopamine to regulate
cystine-glutamate exchange that are not specific to receptor stimulation. However,
dopamine alone lacked an effect on cystine transport ex vivo. There are multiple sources
of inactivation of dopamine signaling. Dopamine can be transported by organic cation
transporter (OCT-3) (Wu et al., 1998) and dopamine transporters (DAT), and is
metabolized by monoamine oxidase. Therefore, we tested a nonspecific dopamine
receptor agonist that is not susceptible to normal metabolism. However, we were also
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unable to alter cystine-glutamate exchange with the nonspecific dopamine agonist
apomorphine. To this end, it may prove valuable to investigate a potential interaction of
long-term increases in dopamine and altered cystine-glutamate exchange. Shih et al. have
previously shown that excessive dopamine signaling in vitro can lead to activation of the
Nrf2 transcription factor and eventual increase in expression of cystine glutamate
exchange (Shih et al., 2007). Assuming this is the case, then one would assume that
animals exhibiting elevated dopamine levels due to cocaine-withdrawal would also
exhibit elevated levels of cystine-glutamate exchange by system xc-. Therefore, future
experiments may investigate this proposed pathway, DA > Nrf2 > system xc-, in cocainewithdrawn animals.
Our inability to regulate cystine-glutamate exchange by dopamine receptors in the
nucleus accumbens core suggests that dopamine does not contribute to diminished
cystine-glutamate exchange during withdrawal from chronic cocaine. In the following
chapter we investigate the ability of a novel neuropeptide, pituitary adenylyl cyclase
activating polypeptide (PACAP) to regulate cystine-glutamate exchange because it has
previously been shown to regulate glutamate homeostasis in the striatum (Figiel and
Engele, 2000).
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CHAPTER 4

Regulation of system xc- by pituitary adenylyl cyclase activating polypeptide
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Introduction
Glutamate homeostasis is altered following withdrawal from cocaine selfadministration due to reduced cystine-glutamate exchange by system xc- (Pierce et al.,
1996, Baker et al., 2003); which can be attributed in part to reduced expression of xCT,
the functional subunit of system xc- (Knackstedt et al., 2010). We are interested in
determining if neurotransmitters and peptides play a role in regulating cystine-glutamate
exchange. Interestingly, a novel neuropeptide, pituitary adenylyl cyclase activating
polypeptide (PACAP) is likely co-released with synaptic glutamate based on findings that
it is produced in the cortex (Mikkelsen et al., 1994, Figiel and Engele, 2000) and is
colocalized with vesicular glutamate transporter 2 (Engelund et al., 2010). PACAP has
also been shown to regulate glutamate homeostasis through glutamate transporters such
as GLT-1 (Figiel and Engele, 2000). Others have found that some treatments leading to
an increase in GLT-1 expression have also increased expression of cystine-glutamate
exchange (Knackstedt et al., 2010)
The aim of this chapter is to determine if PACAP signaling regulates cystineglutamate exchange. We examine PACAP regulation of cystine transport in vitro and ex
vivo. In chapter 3, we were unable to alter cystine-glutamate exchange with receptors
known to couple to Gi and Gs. However, PAC1 receptors are coupled to Gs or Gq. Gq
signaling stimulates Ca2+-dependent protein kinase (PKC), also previously shown to
regulate cystine-glutamate exchange (Tang and Kalivas, 2003). Three G-protein coupled
receptors have relevant affinity for PACAP: PAC1, VPAC1, and VPAC2; with PAC1
having the highest affinity and selectivity for PACAP (Lam et al., 1990). PAC1 receptor
signaling is linked to both Gs or Gq mediated signaling (Holighaus et al., 2011). Further,

81

xCT has consensus phosphorylation sites and is regulated by PKA and PKC as shown in
chapter 2 and previously (Baker et al., 2003, Tang and Kalivas, 2003). Therefore, we
hypothesize that PAC1R activation increases cystine-glutamate exchange based on its
ability to stimulate both PKA and PKC activity (Holighaus et al., 2011).

Materials and Methods
Animals
All experimental protocols were approved by the Marquette University
Institutional Animal Care and Use Committee and carried out according to the NIH
Guide for the Care and Use of Laboratory Animals (revised 1996).
Rat mixed cortical cultures
Mixed cortical cell cultures containing glial and neuronal cells were prepared
from fetal (15–16 day gestation) rat as previously described (Lobner, 2000), with some
exceptions. Dissociated cortical cells were plated on 24-well plates coated with poly-Dlysine and laminin at a density of ~6x105 cells/well in Neurobasal medium supplemented
with 10% fetal bovine serum and 1% Glutamax-I (Life Technologies). Cultures were
maintained in humidified 5% CO2 incubators at 37 °C. Rats were handled in accordance
with a protocol approved by our institutional animal care committee and in compliance
with the Public Health Service Policy on Humane Care and Use of Laboratory Animals.
All efforts were made to minimize animal suffering and reduce the number of animals
used.
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Mouse cortical cultures
Mixed cortical cell cultures containing glial and neuronal cells were prepared
from fetal (15–16 day gestation) mice as previously described (Lobner, 2000).
Dissociated cortical cells were plated on 24-well plates coated with poly-D-lysine and
laminin in Eagles’ Minimal Essential Medium (MEM, Earle’s salts, supplied glutaminefree) supplemented with 5% heat-inactivated horse serum, 5% fetal bovine serum, 2 mM
glutamine and glucose (total 21 mM). Astrocyte enriched glial cultures were prepared as
described for mixed cultures except they are from cortical tissue taken from post-natal
day 1–3 mice (Choi et al., 1987, Schwartz and Wilson, 1992). Cultures were maintained
in humidified 5% CO2 incubators at 37 °C. Mice were handled in accordance with a
protocol approved by our institutional animal care committee and in compliance with the
Public Health Service Policy on Humane Care and Use of Laboratory Animals. All
efforts were made to minimize animal suffering and reduce the number of animals used.
Acute regulation of cystine uptake in vitro
All experiments were performed in a 37ºC bath. As illustrated below, rat mixed
cortical or differentiated striatal astrocyte cultures were washed 3x with 1mL warm
HEPES buffered saline solution, vacuumed to 150 L, then 250 L of the drug was
added to bring to the indicated concentration. Cells incubated for 20 minutes with the
drug, then a small aliquot, 10 L, of HEPES buffered saline solution was added that
brought the concentration of [14C]cystine (Perkin Elmer, Waltham, MA) and TBOA to 1
M and 10 M, respectively. Cells incubated for another 20 minutes. The uptake
experiment was rapidly terminated by wash 3x with 1mL of ice-cold PBS, vacuumed dry,
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and 500 L 0.1% SDS added to solubilize the cells. Resultant lysate was analyzed by
scintillation counter and counts were normalized to the mean of the control group.

3x Wash and drug
application

Cystine application

3x ice-cold PBS wash, and
solubilize
20 minutes

20 minutes
Long-term regulation of cystine uptake in vitro

As illustrated below, mouse cortical cultures cells were treated with indicated
drugs (; or 0 or 100 nM PACAP) for ~48 hours in growth culture media. For the PACAP
antagonist (0 or 10 M PACAP6-38) experiment, mixed cortical culture was used. For
the PACAP38 experiment (0 or 100nM), pure glia were used. On test days, cells were
washed 3x with 1mL HEPES buffered saline solution and vacuumed to 150 mL. Then,
250 L of HEPES buffered saline solution containing cystine to bring the culture media
to one of the following concentrations (CC denotes “cold” cystine, CC* denotes
[14C]cystine): 0.1 M (0.1 M CC*), 0.3 M (0.3 M CC*), 1 M (1 M CC*), 3 M
(1 M CC + 2 M CC*), 10 M (1 M CC + 9 M CC*), or 30 M (3 M CC + 27 M
CC*) as previously described (Fogal et al., 2007). Five minutes later, uptake was rapidly
terminated by washing 3x with 1mL of ice-cold PBS, 250 L of 0.1% SDS was added
and allowed to solubilize the cells. 175 L was used for scintillation counting and 50 L
was used for measuring protein by the BCA method.
Drug Application

~48 hours

3x wash and cystine
application

3x ice-cold PBS wash, and
solubilize
5 minutes
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Aliquots of radiolabeled cystine at 0, 1, 3, and 10 pmoles were measured by scintillation
counter, divided by the cystine content and averaged to determine the specific activity.
Amount of cystine transport was then determined using the following equation:

([S] = concentration of cold cystine, [S*] = concentration of hot cystine)
Cystine transport was normalized to protein to yield transport/g protein.
In order to measure changes in Km or Vmax, uptake data was converted to a
Hanes-Woolf plot by plotting velocity/[CC] against [CC]. For Hanes-Woolf plot,
Vmax=1/slope, and Km= - x-intercept.
Surgeries
Rats were implanted with indwelling catheters under ketamine HCl (100 mg/kg,
IP, Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, IP, Lloyd
Laboratories, Shenandoah, IA, USA) anesthesia. A silicon tubing catheter (Dow Corning
Co., Midland, MI; 0.64 mm ID; 1.19 mm OD) was implanted such that it entered the
jugular vein through the right posterior facial vein and terminated at the right atrium. The
catheter was sutured to the vein at the entry point. The distal aspect of the catheter, which
consisted of a 22-gauge guide cannula (Plastics One Inc., Roanoke, VA) attached with
dental acrylic to a piece of polypropylene monofilament surgical mesh (Atrium Medical,
Co., Hudson, NH), exited 2 cm posterior to the scapulae. Throughout the experiment,
catheters were filled daily with a heparin solution (83 i.u./ml; Elkins-Sinn, Inc., Cherry
Hill, NJ) and capped when disconnected from the leash/delivery line assembly.
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Cocaine Self-Administration Training
Self-administration occurred in operant conditioning chambers (ENV-008CT,
MED-Associates Inc., St Albans, VT, USA) housed in sound attenuating cubicles (ENV016M, MED-Associates Inc.) and equipped with two retractable levers, two stimulus
lights, and a water bottle. At least five days after surgery, rats were food restricted with
water available ad libitum; food restriction continued for the duration of the experiment
(e.g., through reinstatement testing) and involved daily administration of 15 grams of rat
chow in the late afternoon or immediately following an operant session. Rats were then
placed into the operant conditioning chambers overnight and responses on the lever
designated as active resulted in the delivery of food pellets under a fixed ratio 1 schedule
of reinforcement. Daily food training continued until subjects received at least 150 food
rewards in a session, which typically occurred following the first session. During the
acquisition phase of the experiment, all rats underwent drug self-administration training
during daily 2-hr sessions in which operant responses on the active lever were reinforced
with an infusion of cocaine (0.5 mg/kg/200 μl IV, National Institute on Drug Abuse,
Bethesda, MD, USA) under a fixed ratio 1 schedule of reinforcement. Each reinforced
lever response resulted in the illumination of the stimulus light located above the active
lever and was followed by a 25-s time-out period. Responding on a second, inactive lever
located on the back wall was recorded but had no programmed consequences.
Acquisition of cocaine self-administration was operationally defined as < 10% variation
in daily responding over at least three consecutive sessions. During the maintenance
phase of the experiment, rats were assigned to self-administer cocaine under high-intake
conditions (1.0 mg/kg/200 μl IV; 6-hr/day for 11 days).
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Regulation of cystine-glutamate exchange ex vivo
Rats withdrawn from saline or high-intake (1.0 mg/kg/200 mL infusion, i.v., 6
h/d) cocaine self-administration were decapitated and the brains were rapidly extracted
and cut into 1 mm coronal slices using a brain matrix. As illustrated below, tissue
punches (1.25 mm diameter; Stoelting, Wood Dale, IL) were collected from the nucleus
accumbens core (figure 1-4) and incubated at 37°C for ∼30 min on a nylon bolting cloth
platform, submerged beneath 2 mm of standard buffer (Lobner and Lipton, 1993); the
standard buffer contained 124 mM NaCl, 3.0 mM KCl, 1.4 mM KH2PO4, 1.3 mM
MgSO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 4 mM glucose, equilibrated with 95% O2,
5% CO2, pH 7.4. After a 20 min wash, the tissue was incubated for 20 min in standard
buffer containing PACAP (0 – 1 nM), or PACAP (0 or 1 nM) and the cystine-glutamate
exchange blocker sulfasalazine (0 or 500 M). The tissue was transferred to standard
buffer containing [14C]cystine (1 M). DL-TBOA (10 M) was also added to the
incubation buffer to prevent uptake via XAG. After 20 min incubation, the tissue punches
were washed four times in ice-cold PBS and dissolved in 250 μl of 1% SDS. One aliquot
(175 μl) was used to measure [14C]cystine uptake by scintillation counting; a second
aliquot (50 μl) was used to assess protein content by the BCA method.
Tissue extraction

20 minute
equilibration

Drug application
20 minutes

Drug and Cystine

Wash and
solubilize

20 minutes

Statistical analyses
SPSS software (version 16) was used to perform the statistical analyses. When
comparing between two treatments, a Student’s t test was performed. Two way analysis
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of variance (ANOVA) was used with more than one between subject factors (such as
PACAP6-38 and sulfasalazine). Experiments with multiple concentrations of one
treatment utilized ANOVA. Post hoc comparisons were conducted using t-tests when
only two data points were compared, or with Tukey HSD with multiple data points.
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Results
Regulation of xc- by pituitary adenylyl cyclase activating polypeptide
We examined the regulation of cystine-glutamate exchange by PACAP. Figure
4.1 illustrates that exogenous PACAP was not capable of altering [14C]cystine uptake in
mixed cortical cultures from rat
(ANOVA: F4,39=0.830, p=0.515).
Because cortical cultures produce
PACAP endogenously (Figiel and Engele,
2000), we looked to determine if blocking
PACAP signaling in vitro would alter
Figure 4.1. Acute treatment of PACAP in rat
mixed cortical cultures does not affect cystineglutamate exchange. Primary rat mixed cortical
cultures were pretreated with PACAP (0 – 100nM)
and tested for cystine uptake. An ANOVA
revealed no significant change from control
(ANOVA: F4,39=0.830, p=0.515).

[14C]cystine uptake.
Figure 4.2a illustrates that acute
blockade of PAC1Rs with the specific
antagonist PACAP6-38 reduced cystine-

glutamate exchange (ANOVA: F3,55=14.551, p<0.001). Post hoc analyses reveal a
significant effect of 10M PACAP6-38 (Tukey HSD, p<0.001). We then looked to
determine if this decrease in [14C]cystine uptake was specific to cystine-glutamate
exchange. Figure 4.2b illustrates that PACAP signaling regulates [14C]cystine uptake by
system xc-. A two-way ANOVA with PACAP6-38 (0 or 10M) and sulfasalazine (0 or
500M) as between subjects factors yielded significant main effects of PACAP6-38
(F1,12=8.190, p<0.05) and SSZ (F1,12=233.707, p<0.001), as well as an interaction
between the two (F1,12=8.190, p<0.05). Post hoc analyses confirmed a significant effect
of PACAP6-38 in the absence (t6=2.898, p<0.05), but not the presence of SSZ (t6<0.001,
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a
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*

p=1.000). The concentration of PACAP6-38 that induced the significant effect on
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Figure 4.2. PACAP Regulates cystine-glutamate exchange. (a) Acute treatment with the PAC1R
antagonist,
PACAP6-38, showed a significant regulation of cystine uptake in rat primary mixed cortical
100
cultures (ANOVA: F3,55*=14.551, p<0.001;
10M, Tukey HSD, p<0.001). (b) Addition of sulfasalazine (0
Control
80 M) shows PACAP6-38 regulation of cystine-glutamate exchange in ex vivo tissue punches
or 500
10M PACAP6-38
(t6=2.898, p<0.05).
60
40

Protein Kinase C signaling is necessary for PACAP regulation of cystine-glutamate
20
exchange
0

Because PAC1
receptors
0
SSZ can stimulate PKA and PKC (Holighaus et al., 2011),

we examined the role of PKA and PKC signaling in PACAP regulation of cystineglutamate exchange. Figure 4.3a illustrates that PACAP regulation of cystine-glutamate
exchange is not dependent on PKA activity. We treated primary culture with PACAP6-38
(0 or 10M) and the PKA activator dBcAMP (0 or 100M). An ANOVA yielded a
significant effect of treatment (F3,41=9.749, p<0.001). Post hoc analyses revealed a
significant effect of PACAP6-38 (Tukey HSD, p<0.001). However, there was no
significant difference of PACAP6-38 in the presence and absence of dBcAMP (Tukey
HSD, p=0.084).
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We also examined the role of PKC on PACAP regulation of cystine-glutamate
exchange. Figure 4.3b illustrates that PACAP regulation of system xc- activity is
dependent on protein kinase C (PKC) signaling. We treated primary culture with
PACAP6-38 (0 or 10M) and the PKC
activator phorbol 12-myristate 13-acetate
(PMA; 0 or 1M). An ANOVA yielded a
significant effect of treatment
(F3,41=11.573, p<0.001). Post hoc analyses
revealed a significant decrease with
PACAP6-38 (Tukey HSD, p<0.05). In
addition, we measured a significant
difference in cells treated with PACAP638 in the presence or absence of PMA
(Tukey HSD, p<0.001). These findings
suggest that PKC activity is necessary for
Figure 4.3. PACAP regulates cystine-glutamate
exchange in a PKC-dependent manner. Primary
rat mixed cortical cultures were pretreated with
the noted compounds. Pretreatment with the
PACAP receptor antagonist PACAP6-38 (10M)
significantly decreased cystine transport. This
decrease was reversed with the PKC activator
phorbol 12-myristate 13-acetate (PMA, 100nM),
but not with the PKA activator dibutyryl cAMP
(dBcAMP, 100M). *Significant effect from
control. +Significant effect from PACAP6-38
alone.

PACAP regulation of system xc-.
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PACAP regulation of system xc- activity is altered in cocaine-withdrawn animals
Acute treatment with PACAP was
unable to regulate cystine-glutamate
exchange in culture because of endogenous
PACAP release. If this is the case, then we
should be able to appropriately stimulate
PAC1R in ex vivo tissue punches given that
afferent corticostriatal pathways are
denervated. Therefore, we looked to
determine if PACAP signaling regulates

Figure 4.4. PACAP regulates cystine-glutamate
exchange in the nucleus accumbens core.
Pretreatment with PACAP (0 or 1nM) and SSZ
(0 or 500M) showed a significant effect of
PACAP on [14C]cystine transport by system xcin ex vivo tissue punches. *Significant difference
from control.

system xc- activity in the nucleus
accumbens core as it does in vitro by acute application of PACAP. Figure 4.4 illustrates
that PACAP regulates cystine-glutamate exchange in nucleus accumbens core tissue
punches. A two way ANOVA with PACAP (0 or 1nM) and the cystine-glutamate
exchange inhibitor sulfasalazine (SSZ, 0 or 500M) as between subjects factors yielded a
significant main effect of SSZ (F1,19=69.431, p<0.001) as well as an interaction between
PACAP and SSZ (F1,19=6.874, p<0.05), but no main effect of PACAP (F1,19=1.032,
p=0.325). When splitting the groups based on SSZ, a t test comparing the PACAP groups
(0 or 1nM) revealed a significant effect of PACAP in the absence of SSZ (t10=2.563,
p<0.05), but not in the presence of SSZ (t6=1.374, p=0.218).
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We then examined the ability of
PACAP to regulate cystine-glutamate
exchange in animals withdrawn from
cocaine self-administration. Pretreatment
with PACAP resulted in a significant
effect on [14C]cystine transport for drug
naïve animals (Figure 4.5a; ANOVA:
F3,42=2.876, p<0.05), but not for cocainewithdrawn animals (Figure 4.5b;
ANOVA: F3,18=1.670, p=0.216). Post hoc
analyses reveal a significant effect at the
0.1nM concentration for drug naïve
Figure 4.5. PACAP regulation of cystineglutamate exchange in the nucleus accumbens
core is diminished in cocaine-withdrawn animals.
Rats withdrawn from saline (a) or cocaine (b)
self-administration are represented. Drug naïve
animals showed increases in cystine transport
with acute treatment of PACAP (F3,42=2.876,
p<0.05). Animals withdrawn from cocaine selfadministration did not respond to PACAP
(F3,18=1.670, p=0.216). *Significant difference
from control (Tukey HSD, p<0.05).

animals (Tukey HSD, p<0.05).

Tonic PACAP signaling regulates the capacity of cystine-glutamate exchange
The previous findings show that acute PACAP signaling regulates cystineglutamate exchange. However, there is a tonic decrease in cystine-glutamate exchange
during withdrawal from cocaine self-administration. We are interested in what leads to
this long-term diminished system xc- activity. In order to determine if a long-term

93

decrease in PACAP signaling leads to
diminished cystine-glutamate exchange,
mixed cortical cultures were treated with the
PAC1R antagonist PACAP6-38 for 48 hours.
Figure 4.6 illustrates that long-term blockade
of PACAP signaling results in a decrease in
cystine-glutamate exchange. A t test yielded a
significant difference between controls and

Figure 4.6. Tonic PACAP signaling regulates
cystine-glutamate exchange. Blocking PAC1R
receptors for 48 hours in mixed cortical
culture decreases overall cystine uptake
(t30=3.287, p<0.001).

PACAP6-38 (t30=3.287, p<0.001). These
findings suggest that a decrease in PACAP
signaling may contribute to diminished basal
cystine-glutamate exchange in cocainewithdrawn animals.
We wanted to determine if long-term
regulation of xc- by PACAP changes the Km
or Vmax of cystine transport. In order to do
this, we treated pure glial cultures with
PACAP for 48 hours and measured the
kinetic activity of [14C]cystine transport. An
ANOVA with concentration of cystine as a
repeated measure and PACAP (0 or 100 nM)
as a between subjects measure yielded a
significant interaction (figure 4.7a;

Figure 4.7. Tonic PACAP signaling regulates
the capacity (Vmax) of cystine-glutamate
exchange on glia. (a) Plotting [CC] against the
velocity portrays the raw transport data. (b)
The
Hanes-Woolf
plot
allows
for
interpretation of the data. 48 hour incubation
of pure glia by PACAP increases the capacity,
or Vmax, of the transporter (ANOVA:
F1,44=4.259, p<0.05).
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F5,50=2.966, p<0.05). Converting to and analyzing as a Hanes-Woolf plot revealed a
significant increase in the Vmax (figure 4.7b; ANOVA: F1,44=4.259, p<0.05) with PACAP.

Discussion
The aim of this chapter was to determine if PACAP signaling regulates cystineglutamate exchange. PACAP has been previously shown to regulate glutamate
homeostasis by stimulating receptors on astrocytes (Figiel and Engele, 2000). In this
chapter, data is presented suggesting that PACAP also regulates glutamate homeostasis
by stimulating cystine-glutamate exchange.
We first found that acute treatment with PACAP in mixed cortical culture was
unable to alter cystine transport. Interestingly, cortical neurons produce and release
PACAP in vitro (Figiel and Engele, 2000). Therefore, we hypothesized that blocking
endogenous PACAP signaling would be able to decrease cystine-glutamate exchange. To
test this, we treated mixed cortical culture with the selective PAC1R antagonist,
PACAP6-38 and found this was capable of decreasing cystine transport in mixed cortical
culture. There is concern that the concentration of PACAP6-38 required (10M) to
significantly decrease cystine-glutamate exchange is orders of magnitude higher than the
effective concentrations of PACAP (Holighaus et al., 2011). However, the concentration
of PACAP6-38 used was identical to that used by others (Figiel and Engele, 2000). In
addition, our ability to regulate cystine-glutamate exchange in tissue punches from the
nucleus accumbens core by PACAP further supports our findings.
Cystine-glutamate exchange is diminished in the nucleus accumbens core of
cocaine-withdrawn animals (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008),
contributing to cocaine-seeking. In order to determine if PACAP regulation of system xc-
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is altered in cocaine-withdrawn animals, we examined the capacity of PACAP to regulate
cystine-glutamate exchange in tissue punches from the nucleus accumbens core of drug
naïve and cocaine-withdrawn animals.
We found that cystine-glutamate exchange in animals withdrawn from highintake cocaine self-administration is not regulated by PACAP, whereas it was regulated
in drug naïve animals. Lack of phasic (acute) regulation does not fully explain the
decrease in cystine-glutamate exchange we find in ex vivo tissue punches of cocainewithdrawn animals, as seen in chapter 1. Therefore, it is likely that diminished tonic
regulation by PACAP contributes to diminished cystine-glutamate exchange. This
scenario is highly possible given that animals withdrawn from cocaine self-administration
exhibit a form of hyprofrontality (Sun and Rebec, 2006), and PACAP is likely coreleased with glutamate from the prefrontal cortex (Mikkelsen et al., 1994, Engelund et
al., 2010) and possibly explains decreased GLT-1 expression in cocaine-withdrawn
animals (Knackstedt et al., 2010) given that PACAP regulates GLT-1 expression (Figiel
and Engele, 2000). Future studies should attempt to restore PACAP signaling in the
nucleus accumbens core of cocaine-withdrawn animals in an effort to reverse the
cocaine-induced decrease in cystine-glutamate exchange. In addition, future studies will
examine the capacity of exogenous stimulation of PAC1R to alter cocaine-primed
reinstatement in animals that exhibit augmented reinstatement.
Previous findings suggest that tonic PACAP signaling regulates glutamate
homeostasis through glutamate transporters (Figiel and Engele, 2000). We found that
long-term PACAP signaling regulates the maximal capacity of cystine transport in vitro,
suggesting that basal PACAP contributes to the expression of system xc-. What is
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unknown is the mechanism by which long-term PACAP signaling regulates cystineglutamate exchange. Previous studies have shown that PACAP can be considered a
neuroprotectant (Onoue et al., 2002, Deguil et al., 2007, Deguil et al., 2010, Botia et al.,
2011, Endo et al., 2011). The aforementioned studies fall short in determining the
mechanism by which it acts as a neurprotectant. As mentioned previously, it is possible
that neuronal signaling may contribute to cystine-glutamate exchange, a mechanism by
which PACAP as a neuroprotectant can maintain system xc-. PACAP regulates cystineglutamate exchange, also a neuroprotectant through its eventual formation of the
antioxidant glutathione (Kranich et al., 1998), therefore it is possible that PACAPinduced expression of cystine-glutamate is the mechanism by which the neuroprotectant
is working, though future investigation is warranted.
Altogether, these findings suggest that PACAP regulates both short- and longterm activity of cystine-glutamate exchange, and reveals PACAP signaling as a novel
target for cocaine addiction research.
PACAP regulation of cystine-glutamate exchange in vitro
PACAP has been shown to regulate glutamate homeostasis by increasing glialglutamate transport (GLT-1) in vitro (Figiel and Engele, 2000). Interestingly, stimulation
of PAC1R can lead to downstream effects including increases in cAMP and Ca2+ (Tanaka
et al., 1996, Grimaldi and Cavallaro, 1999, Aoyagi and Takahashi, 2001, Mustafa et al.,
2007), however the PACAP-mediated increases in GLT-1 were found to be protein
kinase C (PKC) mediated (Figiel and Engele, 2000). PKC is activated by diacyl glycerol
(DAG) and Ca2+ as a result of activation of Gq coupled receptors. This suggests that the
PACAP-induced increases in GLT-1 expression were calcium mediated. Conversely,
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others have found that PACAP
only increases cAMP and not
Ca2+ in astrocytes (Grimaldi and
Cavallaro, 1999).
In rat mixed cortical
culture, we found that PACAP
was unable to affect cystine
transport. At first this was
surprising giving the existing
presence of PACAP signaling in
basal mixed cortical cultures
(Figiel and Engele, 2000). There

Figure 4.8. PACAP regulates system xc- through PKC.
PAC1Rs activates Gq signaling, stimulating phospholipase
C (PLC). PLC produces inositol trisphosphate (IP 3) and
diacylglycerol (DAG) membrane lipids. IP3 induces release
of Ca2+ from intracellular stores such as the endoplasmic
reticulum (ER). Ca2+ and DAG activate protein kinase C
(PKC). PKC increases activity of cystine-glutamate
exchange. PLC, phospholipase C; IP3, inositol
trisphosphate; ER, endoplasmic reituculum; DAG, diacyl
glycerol; PKC, protein kinase C; AC, adenylyl cyclase;
PKA, protein kinase A.

could be two explanations for the inability of PACAP to stimulate cystine transport in
vitro. First, there is enough basal signaling from neurons in these cultures that the
concentration of PACAP added was not sufficient to overcome the endogenous signaling;
though increasing the concentration of PACAP over that used in these experiments would
lose specificity for the PAC1 receptor. Second, there may be intrinsic activity of the
PAC1R that could not be overcome by adding more PACAP but could only be affected
by the antagonist.
Pretreatment with the selective PAC1R antagonist, PACAP6-38 significantly
decreased cystine transport in these cultures by affecting PKC signaling (figure 4.3b). At
this point, we do not know if PACAP-induced activation of PKC acts directly on system
xc- or through an intermediary. Future studies in our lab will look to determine if xCT,
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the functional subunit of system xc- is directly phosphorylated. To do this, point
mutations at putative phosphorylation sites for xCT will be developed. The Mutated
cDNA can then be transfected into a cell line that lacks significant levels of xCT such as
neurons or HEK293 cells (Shih and Murphy, 2001). This method will allow the
investigator to determine changes in both trafficking and kinetics, potentially revealing
more novel and therapeutic targets for the treatment of cocaine addiction.
Altered Regulation of xc- by PACAP in Cocaine-withdrawn Animals
Cystine-glutamate exchange is diminished in the nucleus accumbens core of
animals withdrawn from cocaine self-administration (Baker et al., 2003, Moran et al.,
2005, Moussawi et al., 2011b). We looked to determine if cystine-glutamate exchange is
regulated by PACAP in drug naïve and cocaine-withdrawn animals. In ex vivo tissue
punches, synaptic signaling is absent due to denervation of the efferent pathways;
therefore, applying PACAP should have an effect on the PAC1R without the concern of
overcoming endogenous PACAP signaling. We found that acute application of PACAP
to ex vivo tissue punches from the nucleus accumbens core was able to significantly
increase cystine-glutamate exchange in drug naïve but not cocaine-withdrawn animals.
It is possible that diminished PACAP regulation of cystine-glutamate exchange in
cocaine-withdrawn animals may be due to diminished PACAP release. However,
currently technology does not allow for accurate measurement of extracellular PACAP in
the brain. In this experimental model, however, the neurons that project PACAP to the
nucleus accumbens core are denervated, effectively eliminating endogenous PACAP
signaling. Therefore, altered receptor signaling, either through receptor expression or
signaling pathways, likely contributes to this effect. Further, PAC1 receptors are
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expressed both on neurons and astrocytes (Grimaldi and Cavallaro, 1999), making it
difficult to identify the source of PACAP regulation of cystine-glutamate exchange. As
mentioned in chapter 3, it is possible that receptor activation on neurons could lead to
regulation of cystine-glutamate exchange. Further studies may reveal the ability to
differentially measure the expression of the receptor on neurons and astrocytes, which
could allow an experimenter to further investigate the contribution of cocaine to altered
PACAP signaling.
Pituitary adenylyl cyclase activating polypeptide (PACAP) regulates glutamate
homeostasis by maintaining glial glutamate transport (Figiel and Engele, 2000) and
cystine-glutamate exchange, as shown in this chapter. Animals withdrawn from cocaine
self-administration show diminished cystine-glutamate exchange and basal extracellular
glutamate in the nucleus accumbens (Baker et al., 2003, Moran et al., 2005, Kau et al.,
2008, Moussawi et al., 2011b). Though PACAP regulated cystine-glutamate exchange in
the nucleus accumbens core of drug naïve animals, cocaine-withdrawn animals did not
exhibit that effect. This suggests that basal extracellular glutamate is regulated in an acute
manner by PACAP. Our findings are novel in that acute regulation of cystine-glutamate
exchange is rarely investigated, PACAP regulation of cystine-glutamate exchange has
never been reported, and certainly the deficit found in PACAP signaling in cocainewithdrawn animals has never been discovered.
Figiel and Engele (2000) increased glial glutamate transport by long-term
application of PACAP. We wanted to determine if system xc- responds in the same
manner. Just as with glial glutamate transport, we found that 48 hour treatment of the
PAC1R antagonist, PACAP6-38 led to a decrease in cystine transport in mixed culture.
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To investigate further, we applied PACAP to pure glial cultures for 48 hours. Though
there was no change in the binding affinity, Km, we did find a significant increase in the
full efficacy, or Vmax. These findings suggest that PACAP signaling plays an extremely
important role in glutamate homeostasis due to the fact that it regulates both the source of
extrasynaptic, nonvesicular glutamate as well as the mechanism for clearance (Figiel and
Engele, 2000). This likely effects the regulation of synaptic transmission as cystineglutamate exchange regulates synaptic release (Baker et al., 2002), and that glutamate
transport is necessary for synaptic clearance and maintaining the distinct pools of
extracellular glutamate (Danbolt, 2001).
Chapter 1 showed that amount of cocaine-intake leads to differing levels of
neuroplasticity. For example, animals withdrawn from high-intake cocaine selfadministration exhibited augmented extracellular dopamine in the nucleus accumbens
after a cocaine injection when compared to animals withdrawn from low-intake cocaine.
It was mentioned earlier that these conditions reveal a more accurate assessment of
neuroplasticity following chronic cocaine. The current studies compared drug naïve and
animals withdrawn from high-intake cocaine self-administration, therefore it may prove
valuable to repeat the current study to include animals withdrawn from low-intake
cocaine self-administration conditions.
Historically, investigators have suggested that corticostriatal pathways regulate
extracellular dopamine by targeting presynaptic terminals of midbrain dopaminergic
neurons directly (Stewart, 2000, Schmidt et al., 2005, Thomas et al., 2008). Our findings
suggest that a novel method of regulating dopamine release may converge at cystineglutamate exchange. Not much is known as to the contribution of hypofrontality to the
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neuropathology of addiction. We find that PACAP regulates cystine-glutamate exchange
both tonic and acutely. As well, cystine-glutamate exchange regulates dopamine release,
which contributes to elevated reinstatement. Therefore, diminished corticostriatal, and
therefore PACAP signaling may contribute to augmented dopamine and relapse
vulnerability.
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CHAPTER 5
DISCUSSION
Compulsive cocaine seeking emerges after chronic use that is thought to be the
direct result of drug-induced plasticity (Hyman and Malenka, 2001, Pierce and
Vanderschuren, 2010). Cystine-glutamate exchange has been previously identified as a
mechanism effected by chronic cocaine and contributes to multiple aspects of addiction
(Baker et al., 2003, Moran et al., 2005, Kau et al., 2008, Moussawi et al., 2011b).
Interestingly, previous studies have found that targeting cystine-glutamate exchange an
effective treatment for drug craving in humans (Baker et al., 2003, Moran et al., 2005,
Kau et al., 2008, Moussawi et al., 2011b). The purpose of the experiments in this
dissertation was to better understand cystine-glutamate exchange by system xc- in terms
of the impact that diminished cystine-glutamate exchange has on behaviors used to model
cocaine addiction, and its regulation at the cellular level to begin to understand how it
may be reduced following repeated cocaine. Our primary findings were the following:






Decreased basal extracellular glutamate due to diminished cystineglutamate exchange contributes to augmented cocaine-evoked dopamine
and heightened relapse vulnerability
D1-like dopamine receptors regulate system xc- activity in mixed cortical
culture, but not tissue punches from the nucleus accumbens core
PACAP acutely regulates cystine-glutamate exchange both in mixed
cortical culture and in tissue punches from the nucleus accumbens core
In animals withdrawn from cocaine self-administration, PACAP does not
regulate system xc- activity
Long-term PACAP signaling regulates the maximal capacity of system xcsuggesting a source of diminished cystine-glutamate exchange in cocaine
withdrawn animals
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Diminished system xc- contributes to relapse vulnerability
We found that diminished cystine-glutamate exchange led to neuroplasticity and
cocaine-seeking following withdrawal from cocaine self-administration. By manipulating
conditions that restore basal glutamate and functional cystine-glutamate exchange, we
were able to determine the contribution of altered extracellular glutamate in cocaineprimed reinstatement. Our findings show that diminished basal glutamate due to
diminished cystine-glutamate exchange is essential to cocaine-primed reinstatement and
cocaine-evoked extracellular glutamate.
Glutamate release into the nucleus accumbens core is necessary for cocaineprimed reinstatement (McFarland et al., 2003), therefore we hypothesized that animals
exhibiting augmented cocaine-primed reinstatement would also show elevated cocaineevoked extracellular glutamate. However, we did not detect a difference in cocaineevoked glutamate despite the fact that animals receiving high-intake cocaine had
diminished cystine-glutamate exchange. A possible explanation for this is findings by
others that suggest uncoupling of presynaptic inhibitory Group II autorceptors in the
nucleus accumbens core (Xi et al., 2002b). Conversely, we did find elevated cocaineevoked dopamine in animals that consumed higher levels of cocaine. This was surprising
as glutamate (McFarland et al., 2003) but not dopamine (McFarland and Kalivas, 2001,
Anderson et al., 2003) is necessary for cocaine-primed reinstatement. Further, acute
stimulation of cystine-glutamate exchange with N-acetylcysteine reversed the augmented
cocaine-evoked dopamine response as well as decreased reinstatement. This suggests that
diminished cystine-glutamate exchange contributes to augmented cocaine-evoked

104

dopamine. While glutamate signaling is necessary for cocaine-primed reinstatement,
these findings reveal dopamine as a likely contributor to heightened relapse vulnerability.
Diminished cystine-glutamate exchange in cocaine-withdrawn animals: contribution of
dysregulation by neurotransmission
In chapter 3, we examined the ability of dopamine to regulate cystine-glutamate
exchange given that animals exhibiting augmented dopamine signaling also show
heightened reinstatement. We did find a significant increase in [14C]cystine transport in
mixed cortical cultures treated with a D1-like receptor agonist. However, we found no
regulation of cystine-glutamate exchange in nucleus accumbens core tissue punches by a
D1-like dopamine receptor agonist. The differential regulation of system xc- by D1
receptors was not expected. However, in tissue punches corticostriatal projections are
eliminated, whereas in mixed cortical cultures cortical neuronal signaling remains intact.
Therefore, it is possible that there is a contribution of dopamine regulation of
corticostriatal signaling that regulates cystine-glutamate exchange. In support of this,
findings by others suggest that acute stimulation of the prefrontal cortex by BDNF both
restores basal glutamate in the nucleus accumbens and reduces cocaine seeking in
cocaine-withdrawn animals (Berglind et al., 2007, Berglind et al., 2009). Our findings
suggests the scenario that corticostriatal signaling regulates cystine-glutamate exchange,
a phenomenon that could not be parsed out in a 1mm tissue punch from the nucleus
accumbens core. Future experiments should investigate D1-like receptor stimulation in
the prefrontal cortex and its contribution to cystine-glutamate exchange in the nucleus
accumbens core. This idea is significant due to the fact that we showed regulation of
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system xc- by the cortical derived neuropeptide pituitary adenylyl cyclase activating
polypeptide (PACAP).
In addition to investigating regulation of xc- by D1-like dopamine receptors, we
also looked into regulation by D2-like receptors. We were unable to alter system xcactivity by stimulating D2-like dopamine receptors in vitro even though these receptors
are Gi-linked and we were able to decrease cystine-glutamate exchange by inhibiting
PKA activity in glioma culture.
We also wanted to determine if nonspecific dopamine signaling regulates cystineglutamate exchange. Oxidative stress is capable of increasing system xc- activity (Allen et
al., 2002, Dun et al., 2006, Lewerenz et al., 2006). Therefore, we considered the
possibility that dopamine may regulate cystine-glutamate exchange by non-receptor
mediated mechanisms such as oxidative stress through metabolism or auto-oxidation
(Rabinovic and Hastings, 1998, LaVoie and Hastings, 1999). However, dopamine alone
lacked an effect on cystine transport ex vivo. Taking into account that dopamine can be
inactivated through metabolism or uptake, we also tested apomorphine because it is a
nonspecific dopamine receptor agonist that is not susceptible to normal metabolism. We
did not find altered cystine-glutamate exchange in the presence of apomorphine. Further,
there exists D1-D2 dopamine receptor heterodimers that are Gq-linked (Rashid et al.,
2007), and binding of both the D1 and D2 receptor subunit is necessary for the
downstream Ca2+ response. In support of our design, apomorphine is capable of binding
to both receptor subtypes, suggesting that the heterodimer does not regulate cystineglutamate exchange
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We then decided to investigate a pituitary adenylyl cyclase activating polypeptide
(PACAP) as a potential regulator of cystine-glutamate exchange. PACAP is likely coreleased with glutamate based on the facts that it colocalizes with vesicular glutamate
transporter 2 (VGLUT2) (Engelund et al., 2010) and that PACAP is produced in regions
with glutamate projecting neurons such as the cortex (Mikkelsen et al., 1994, Figiel and
Engele, 2000). As well, PACAP signaling regulates glutamate homeostasis by increasing
glial glutamate transporter expression through a PKC-dependent mechanism (Figiel and
Engele, 2000). We found that PACAP did indeed regulate system xc- activity in mixed
cortical cultures and tissue punches from the nucleus accumbens core, an effect
dependent on PKC activity. More importantly, we found that cystine-glutamate exchange
in the nucleus accumbens core of animals withdrawn from cocaine self-administration
did not exhibit regulation of cystine-glutamate exchange by PACAP. These findings
suggest that cystine-glutamate exchange is dysregulated by altered PACAP signaling in
animals withdrawn from chronic cocaine.
As mentioned previously, PACAP mediates glutamate homeostasis by tonic
regulation of GLT-1 function (Figiel and Engele, 2000). Interestingly, GLT-1 function
has been previously shown diminished in the nucleus accumbens core of animals
withdrawn from cocaine self-administration (Knackstedt et al., 2010). In the mentioned
study, treatment with the -lactam antibiotic, ceftriaxone restored GLT-1 and system xcin cocaine-withdrawn animals, suggesting that expression of GLT-1 and cystineglutamate exchange are linked. Because PACAP tonically regulates GLT-1 function, we
hypothesized that it also tonically regulates cystine-glutamate exchange. We found that
long-term blockade of PACAP signaling in mixed cortical cultures that endogenously
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produce PACAP resulted in a decreased in system xc- activity. We then looked to
determine if long-term PACAP signaling regulates cystine-glutamate exchange
particularly on astrocytes. When treating glial cultures with PACAP for 48 hours, we
measured an increase in the maximal capacity of cystine-glutamate exchange.
Pituitary adenylyl cyclase activating polypeptide (PACAP) and its contribution to altered
neurotransmission
PACAP is a novel neuropeptide likely co-released with synaptic glutamate in the
nucleus accumbens core due to the fact that PACAP mRNA is found in regions that
produce PACAP (Mikkelsen et al., 1994), is colabeled with vesicular glutamate
transporter 2 (VGLUT2) (Engelund et al., 2010), and PAC1 receptors are found in the
nucleus accumbens (Hannibal, 2002). This is significant because we found that PACAP
regulates cystine-glutamate exchange in mixed cortical culture in a PKC-dependent
manner. Given that cystine-glutamate exchange is diminished in the nucleus accumbens
core in animals withdrawn from cocaine self-administration, we looked to determine if
PACAP regulates system xc- activity in the nucleus accumbens core. We found that
PACAP does regulate cystine-glutamate in the nucleus accumbens core. Interestingly, we
found that PACAP regulation of cystine-glutamate exchange is diminished in animals
withdrawn from cocaine self-administration.
Hypofrontality is a phenomenon described by decreased basal activity of the
frontal cortical regions of the brain during a disorder such as cocaine addiction (Sun and
Rebec, 2006) and schizophrenia (Jacquy et al., 1976, Buchsbaum and Wu, 1987).
Interestingly, system xc- is diminished in both disorders (Baker et al., 2003, Baker et al.,
2008). As mentioned previously, PACAP derives from cortical regions and is likely co-
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released with synaptic glutamate. Therefore, if PACAP signaling is diminished due to
hypofrontality, one may expect this is a major contributor to the decrease found in
cystine-glutamate exchange (Baker et al., 2003, Moran et al., 2005, Kau et al., 2008,
Knackstedt et al., 2010, Moussawi et al., 2011b) and GLT-1 (Knackstedt et al., 2010) in
cocaine-withdrawn animals. Investigators may also benefit from investigation of PACAP
signaling in the neuropathology of schizophrenia.
PAC1 receptors are both Gs- and Gq-coupled (Holighaus et al., 2011). However,
we found that PACAP regulation of cystine-glutamate exchange is a PKC-dependent
effect, implicating a Gq-coupled mechanism. In addition, we were unable to regulate
system xc- activity by a Gs-coupled receptor such as D1-like dopamine receptors. This is
in line with previous findings that PACAP regulation of GLT-1 expression is dependent
on PKC signaling. Another metabotropic receptor that is also coupled to Gq and is found
on astrocytes is Group I metabotropic glutamate receptors, specifically mGluR5. If
hypofrontality contributes to altered glutamate homeostasis due to diminished activation
of PAC1 receptors, it is likely that diminished basal glutamate, both synaptic and through
cystine-glutamate exchange, is insufficient to stimulate mGluR5. Therefore, future
studies should investigate other Gq-coupled receptors, in particular mGluR5, and their
role in altered glutamate homeostasis.
System xc-: a novel convergence of corticostriatal and midbrain dopaminergic signaling
Historically, investigators have suggested that corticostriatal pathways regulate
extracellular dopamine by targeting presynaptic terminals of midbrain dopaminergic
neurons directly (Stewart, 2000, Schmidt et al., 2005, Thomas et al., 2008). Our findings
suggest that a novel method of regulating dopamine release may converge at cystine-
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glutamate exchange. Until now, not much is known as to the contribution of
hypofrontality to the neuropathology of addiction. We find that the cortical-derived
neuropeptide, PACAP regulates cystine-glutamate exchange both tonic and acutely. As
well, cystine-glutamate exchange regulates dopamine release, which contributes to
elevated reinstatement. Therefore, diminished corticostriatal signaling, in part through
PACAP, may contribute to augmented dopamine release into the nucleus accumbens core
and heightened relapse vulnerability.
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